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ABSTRACT
Elisha, Leanne. Perinatal Mental Health: Improving the Quality and Consistency of
Health Care Delivery in Kootenai County. Unpublished Doctor of Nursing
Practice scholarly project, University of Northern Colorado, 2019.
Perinatal mental health issues including depression, anxiety, posttraumatic stress
disorder, mania, and psychosis occur frequently during pregnancy and after delivery;
these issues have potentially devastating impacts on mothers, infants, other family
members, and communities. Despite increasing awareness of perinatal mental health
issues and formal recommendations to implement universal screening and ensure access
to appropriate follow-up, there is wide variation in clinical practice across regions and
providers. Inconsistent screening, paired with limited local resources for follow up,
might prevent women from receiving appropriate treatment. The objective of this project
was to develop a guide for clinician use to improve screening, referral, and follow up of
perinatal mental health issues. The guide identifies an appropriate screening instrument,
screening intervals, methods, recording practices, and follow-up recommendations.
Additionally, an integrated mental health model was proposed for ongoing treatment and
coordination of care. The project was developed using the Delphi method and ongoing
engagement with seven local stakeholders to create a streamlined, consistent process that
would match clinician needs with available resources.
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CHAPTER I
INTRODUCTION
Perinatal mood and anxiety disorders (PMADs) are one of the most common
complications of pregnancy and childbirth. It is estimated that across the population, up
to one in seven women who are pregnant or give birth have experienced PMAD
symptoms with even higher incidence in women with elevated risk factors (Earls, 2010;
O’Hara & Wisner, 2014). Perinatal mood and anxiety disorders can occur at any time
during pregnancy or the postpartum period and include depression, anxiety, mania, and
psychosis (Hanley, 2009). These disorders may be debilitating for women and can
interfere with infant attachment and bonding, possibly impacting families for generations.
Perinatal mood and anxiety disorders also impact fathers, same-sex parents, grandparents,
and siblings. Anxiety and depression during pregnancy are independent risk factors for
cesarean delivery, preterm birth, and low birth weight (Hanley & Oberlander, 2014).
Babies born to women experiencing PMADs often require higher levels of care in early
infancy and frequently have difficulty with sleep and temperament (Hoffman, Dunn, &
Njoroge, 2017). Severe maternal stress during the first trimester has been associated with
increased risk of congenital malformations; prenatal stress at any point during pregnancy
increases the risk of depression, anxiety, and behavioral issues in offspring (Glover,
2014; Hoffman et al., 2017).
Despite increasing awareness of PMADs and their impact, as well as
recommendations from professional organizations including the American College of
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Obstetricians and Gynecologist (ACOG, 2016), the U.S. Preventive Services Task Force
(USPSTF, 2018), and the American Academy of Pediatrics (AAP, Earls, 2010), many of
the providers who care for pregnant/postpartum women and their babies do not routinely
screen for these disorders, leaving many women without proper diagnosis and treatment
(Cox, Sowa, Meltzer-Brody, & Gaynes, 2016). Reasons often cited for not routinely
screening for PMADs include lack of time, lack of institutional support, and unfamiliarity
or discomfort with mental health issues. Even if women are screened and identified as
having or being at risk for developing PMADs, providers often lack access to appropriate
resources to which the women could be referred. Developing comprehensive practice
guidelines for screening, assessment, referral, and treatment of PMADs might improve
outcomes for women, their children, their families, and communities (Cox et al., 2016;
Evans, Phillippi, & Gee, 2015).
Significance of the Problem
Kootenai County is located in the northern “panhandle” region of Idaho. Home to
some 150,000 people, an estimated 1,800 babies are born in the county annually.
Approximately 53% of prenatal, obstetric, and postnatal care is rendered by providers at
Kootenai Health (2018), a community-owned hospital. Until recently, Kootenai Health
had not had any formal guidelines or protocols to direct screening for perinatal mental
health issues. Within the past 24 months, the outpatient obstetrics-gynecology clinic has
begun screening women at the first obstetric (OB) visit using the Patient Health
Questionnaire-2 (PHQ; Kroenke, Spitzer, & Williams, 2003), and the PHQ-9 (Kroenke,
Spitzer, & Williams, 2001) at the six-week postpartum visit. Beyond this, there are no
organizational guidelines for treatment or referral. Currently, no universal screening
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process is in place at the inpatient Family Birth Center (comprised of labor and delivery,
post-partum, and a neonatal intensive care unit (NICU)). Informal discussions with staff
and leadership on the outpatient and inpatient sides of prenatal and obstetric care
indicated a high level of interest in receiving education, support, and assistance in
implementing routine screening, treatment, and referral.
Several organizations in the community provide outpatient mental health services
including psychotherapy, support groups, and medication management. Several
providers (including this writer) have interest and experience in treating PMADs but no
formal system for referral exists between agencies nor is there any process for expediting
treatment of women in urgent need of mental health assistance.
Gap Analysis
On national, state, and local levels, significant gaps exist between
recommendations and actual clinical practice when it comes to screening, identification,
and treatment of PMADs. A meta-analysis by Yawn et al. (2012) found, “Despite nearly
universal health care encounters at some time during [the perinatal period], only about
50% of women with significant depressive symptoms are recognized” (p. 1). Women
with less pronounced symptoms are often less likely to be identified, especially when
there is no formal, routine mechanism for assessment.
In a 2015 review of literature, Evans, Phillippi et al. found that across obstetric,
pediatric, and family practitioners, 3 in 10 rarely or never assessed for postpartum
depression (PPD). Slightly more than half of providers responded they “ever,”
“sometimes,” “often,” or “always” assessed for PPD but, overall, only one in four
routinely used a validated screening instrument. The same authors found that while a
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majority of providers in pediatrics, family practice, and obstetrics (OB) felt it was their
responsibility to identify PPD, most of these providers reported feeling lack of
confidence in their ability to do so. Additional identified barriers to screening included
time constraints, financial disincentives, concern over liability, inadequate availability of
mental health services, and the perception that mothers did not want to disclose or discuss
symptoms (Evans, Phillippi et al., 2015).
Even if screening is completed, multiple barriers can prevent women from
receiving appropriate treatment including external barriers (lack of local resources, lack
of insurance coverage) and internal barriers (avolition, shame, and stigma). Cox et al.
(2016) found only 15.8% of women identified as having PPD received treatment and only
6.3% received “adequate” treatment. Goodman (2009) found most women (92%) said
they would engage in individual therapy to treat PPD if it was recommended and
available. Women indicated a preference to receive treatment in their OB providers’
office, either by the obstetric provider or by a mental health professional. Even if women
with or at high-risk for PMADs were identified and referred to a mental health
professional for further assessment and treatment, follow-through was variable. Puryear
(2018) found in women identified as being high-risk for PMADs, the rate of completed
follow-up for mental health evaluation was only 21.1% when the mental health
provider’s office was in a separate location from the OB provider’s office but as high as
81.1% when the mental health provider was embedded in the OB office.
Very little published information is available regarding incidence or treatment of
PMADs in Idaho but abundant data indicate that mental health services in Idaho are
generally inadequate and unable to match the needs of the population. According to
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Mental Health America (2018), a national non-profit mental health advocacy
organization, Idaho ranked 42 out of 51 (U.S. states and the District of Columbia) in
terms of access to mental health care. In 2016, Idaho had the eighth highest suicide rate
in the nation with 20.8 completed suicides per 100,000 residents. This rate is 50% higher
than the national average, and makes suicide the second-leading cause of death of
Idahoans between ages 15-34 (Idaho Department of Health and Welfare; Suicide
Prevention Program, n.d.).
In Kootenai County (n.d.), the third most populous county in Idaho, mental health
services are provided by a variety of agencies including the community-owned hospital,
the State Department of Health and Welfare, for-profit clinics, independent practitioners,
and a federally qualified health center. The community’s largest outpatient mental health
provider is the federally qualified health center (Heritage Health), which provides
primary care, dental, and mental health services to several thousand clients annually. The
mental health department is comprised of Heritage Mental Health, which provides
primarily psychotropic medication management, and Family Support Services, which
provides psychotherapy, community-based rehabilitation services, assertive community
treatment, and an intensive outpatient treatment program. Together, the departments
employ 27 clinicians (primarily master’s level professional therapists or clinical social
workers), two full-time psychiatric physician assistants (PAs), and one full-time
psychiatric nurse practitioner (NP, Kootenai County, n.d.). According to personal
communication with the directors of Heritage Mental Health and Family Support
Services, the average wait times for new-patient appointments for medication
management and psychotherapy are two to three months and six to eight weeks,
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respectively. Both agreed no formal systems were in place for expedited referral for
patients needing urgent care (including those with PMADs), and that such a system
would greatly benefit the community.
A preliminary survey of OB providers at Kootenai Clinic indicated many were
starting to screen patients for PMADs in the outpatient setting and were aware of the
importance of doing so—yet barriers persisted. First, most providers who responded to
the survey reported that despite screening regularly and being “familiar with screening
recommendations,” they were not familiar with the Edinburgh Postnatal Depression Scale
(EPDS; Mcbride, Wiens, Mcdonald, Cox, & Chan, 2014)—one of the most highlyvalidated and recommended tools for screening in the perinatal period. Despite recently
implementing some screening into prenatal and postpartum care, detection of PMADs
was still very low. The Kootenai Clinic’s obstetrics-gynecology practice informally
estimated they encountered one case of PPD per month but based on delivery rates and
national incidence of PMADs, the number of affected women was likely more than 10
times higher (J. Stotz, personal communication, October 2018). A subsequent review of
depression screening in the OB clinic using the PHQ-9 (Kroenke et al., 2001), a validated
instrument used widely in primary care, indicated nearly one in five women (18.5%)
rated “moderate/severe” or “severe” depression symptoms.
Responses indicated that while some OB providers felt comfortable discussing
mental health issues with perinatal women, they did not feel familiar with local resources
for follow-up treatment. Most respondents (80%) indicated that having a standardized
guideline to standardize screening, referral, and follow up across clinical settings would
greatly improve access to care and outcomes in this vulnerable population.
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Background and Significance of Perinatal Mood
and Anxiety Disorders
Suicide Statistics
In the developed world, suicide is a leading cause of maternal death during
pregnancy and the first 12 months postpartum. In the United States, more maternal
deaths are due to suicide than to either hemorrhage or hypertensive disorders (Palladino,
Singh, Campbell, Flynn, & Gold, 2011). A recent study in Ontario, Canada, revealed 1 in
19 maternal deaths was attributable to suicide (Grigoriadis et al., 2017). The authors also
noted these numbers were likely underreported (death certificates did not always
accurately reflect pregnancy or recent childbirth) and underestimated (many only
considered the postpartum period to extend six weeks after delivery), making the actual
estimated incidence of perinatal suicide strikingly high. According to a study in the
United Kingdom from 1997-1999, 10% of all postpartum deaths were the result of
suicide (Oates, 2003). Evidence suggested the methods by which pregnant and
postpartum women committed suicide were more violent than non-perinatal suicides
(more likely to hang selves or jump; Palladino et al., 2011).
Impact of Perinatal Mood and
Anxiety Disorders on Children
The effects of PMADs are not limited to mothers; they extend throughout the
family and impact babies, siblings, partners, and communities. The health impacts on
babies of women experiencing PMADs have been well documented. Severe maternal
stress during the first trimester is associated with increased risk of congenital
malformations (Glover, 2014). Anxiety and depression during pregnancy have been
identified as independent risk factors for caesarean delivery, preterm birth, and low birth
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weight (Hanley & Oberlander, 2014). Poor growth and reduced rates of breastfeeding
(especially in first time mothers) are also potential effects of PMADs (Toler, Stapleton,
Kertsburg, Callahan, & Tolsma, 2018).
Babies born to mothers struggling with PMADs often require higher levels of care
in early infancy. They frequently have difficulty with sleep and temperament and are at
elevated risk of depression, anxiety, and behavioral issues (Glover, 2014). These infants
are at risk of developing impaired social interactions, developmental delays, and
language acquisition (Earls, 2010; Hoffman et al., 2017). Impaired attachment and
bonding can impede brain development in a neglected infant to the point that magnetic
resonance imaging scans reveal visible, negative changes to brain structure (Earls,
2010). They may develop insecure attachment, putting them at risk for behavior
problems later in life (Hoffman et al., 2017).
Seymour, Giallo, Cooklin, and Dunning (2014) noted women with postpartum
anxiety may be “insensitive to infants’ cues,” (p. 315), which can interfere with their
ability to bond appropriately with their children. Adverse effects of impaired attachment
become more entrenched and resistant to intervention over time, highlighting the need for
early detection and intervention for depressed mothers (Hoffman et al., 2017; Seymour et
al., 2014).
Impact of Perinatal Mood and
Anxiety Disorders on Family
Perinatal depression often has a ripple effect on the entire family system. If a
mother experiences postpartum depression, her partner is more likely to also experience
depression (Earls, 2010). A correlation (though not clear causation) exists among
perinatal depression and marital problems, substance abuse, and child abuse/neglect
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(Norhayati, Hazlina, Asrenee, & Emilin, 2015). Parental depression could lead to poor
implementation of recommended safety measures (i.e., using car seats properly or
following safe-sleep guidelines) and excessive utilization of healthcare resources (Earls,
2010).
Financial Impacts of Perinatal Mood
and Anxiety Disorders
Limited data exist regarding specific financial impacts of PMADs but much
research confirmed the significant financial burden of depression in the United States and
around the world. Greenberg, Fournier, Sisitsky, Pike, and Kessler (2015) estimated the
economic burden of depression (major depressive disorder, bipolar depression, and
dysthymia) in the United States in 2010 to be approximately $81.1 billion. The financial
impacts of mental illness are multifactorial and include lost wages, lower productivity
(due to missing work and struggling with cognitive challenges even if present at work),
and significant medical comorbidities associated with increased healthcare utilization and
spending (Greenberg et al., 2015; Kessler, 2012). In 2004, depression was the fourth
leading cause of disability adjusted life-years (DALY), a measure of life lost to premature
death and years lived with disability (Briley & Lepine, 2011). The World Health
Organization (WHO, cited in Briley & Lepine, 2011) estimated that by 2030, depression
would become the leading cause of DALY.
Diaz and Chase (2010) estimated the annual cost of untreated maternal depression
is $22,647 per mother/infant dyad. This included lost wages and lower productivity by
the mother, increased healthcare costs associated with the infant born to a depressed
mother (risk of low birth rate, pre-term delivery), and downstream financial impacts to
the child due to those complications. Cox et al. (2016) extrapolated that in 2008 this
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could have accounted for almost $15 billion annually. It should be noted these financial
estimates focused entirely on the economic burden of depression. The impacts of
anxiety, posttraumatic stress disorder (PTSD), mania, and psychosis were not quantified
in the literature and likely carried equally high economic impacts.
Risk Factors for Perinatal Mood
and Anxiety Disorders
Multiple factors elevate a woman’s risk of developing PMADs including history
of anxiety or depression, history of interpersonal violence, adverse life events, unplanned
pregnancy, physical illness or pregnancy complications, multiple births, sleep
disturbance, low social and/or partner support, high perceived stress, high perceived
childcare need, and low self-esteem (Paschetta et al., 2014; Toler et al., 2018). The
strongest predictive risk factors for perinatal depression are history of depression
(perinatal or non-perinatal episodes) along with psychosocial factors (O’Hara & Wisner,
2014; Paschetta et al., 2014;).
Personal or family history of psychotic disorders, previous episodes of postpartum
psychosis, younger age, and sleep disturbance increase the risk of postpartum psychosis
(Paschetta et al., 2014). Pregnancy complications including severe preeclampsia,
cesarean delivery, lower birth weight, NICU admission, and perinatal death increase the
risk of PTSD (Paschetta et al., 2014).
Definition of Terms
Two main diagnostic classifications systems used in psychiatry in the United
States are the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5, American Psychiatric Association, 2013) and the 10th edition of the
International Classification of Diseases (ICD-10) published by the WHO (2018). Each
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system uses a different, but sometimes overlapping, taxonomy to describe PMADs. The
DSM criteria are used widely for diagnostic and treatment purposes, while ICD-10
criteria are used primarily for coding and billing.
Neither the DSM-5 (APA, 2013) nor the ICD-10 (WHO, 2018) recognize
postpartum depression as a separate diagnostic category. According to the DSM-5, if the
patient meets diagnostic criteria for a major depressive episode (five out of nine
neurovegetative symptoms present nearly every day within a two week period, symptoms
not attributed to another condition, and symptoms caused significant distress or
impairment), the specifier of “with peripartum-onset” is to be added if symptoms began
during pregnancy or within four weeks of delivery (ICD-10 expanded the postpartum
period to six weeks after delivery; WHO, 2018). The peripartum-onset specifier may
also be added to episodes of Bipolar I and Bipolar II Disorders (including episodes of
mania, hypomania, and depression; APA, 2013).
Organizations devoted to improving identification and treatment of PMADs,
including Postpartum Support International (PSI; Segre & Davis, 2013) and the Marcé
Society (Austin, 2014), have advocated for expansion of the “peripartum-onset” modifier
to include onset within the first six months after delivery. In studies of postpartum
women, depressive symptoms peak at six weeks, two to three months, and six months
after delivery, rendering the four-week onset requirement overly restrictive and
exclusionary (Earls, 2010; Sharma & Mazmanian, 2014). Additionally, these
organizations support application of this modifier to episodes of brief psychotic disorder,
mixed depression and anxiety disorder, and obsessive compulsive disorder (Segre &
Davis, 2013). Postpartum Support International’s rationale for this expansion included
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acknowledgement that many women who suffer from PMADs present to their primary
care and obstetric providers with mixed symptoms of anxiety and depression and these
diagnoses more accurately reflect their clinical presentations. Of high concern was the
incidence of obsessive compulsive disorder (OCD), which is very common in the
postpartum period. Symptoms include intrusive and ego-dystonic thoughts of harming
oneself or one’s infant. If not properly assessed and diagnosed, these thoughts are often
mistaken for psychosis and women might be wrongly accused of being potential threats
to themselves or their children, which delays treatment and can—in worst case
scenarios—result in inappropriate engagement of child protective services (Segre &
Davis, 2013). If clinicians are able to confidently rely on DSM criteria to assess patients
and therefore direct treatment, outcomes will be improved.
As DSM-5 (APA, 2013) and ICD-10 (WHO, 2018) taxonomy have limited use in
clinical practice, many stakeholders—including mental health professionals and
obstetric/gynecological providers—have developed pragmatic, clinically useful terms for
describing mental health issues in the perinatal period (Milgrom & Gemmill, 2014).
Mood, anxiety, and psychotic disorders exist on a spectrum ranging from mild depression
and anxiety to severe, life-threatening depression and psychosis. Definitions and
parameters might vary across clinical settings or cultures but the general consensus is
these disorders begin during pregnancy or within the first 12 months after delivery (Earls,
2010; Norhayati et al., 2015; O’Hara & Wisner, 2014). It should also be noted that
preexisting mental health disorders may be exacerbated during this time period
(Fairbrother, Young, Janssen, Antony, & Tucker, 2015; Norhayati et al., 2015).
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Baby blues. Mild or moderate symptoms that usually occur in the first few days or week
after delivery. It is estimated that between 50-80% of postpartum women
experience these symptoms including sadness, mood swings, tearfulness, anxiety,
and worry. These symptoms might be distressing but do not interfere with
functioning and usually resolve within one to two weeks with support and
reassurance (Earls, 2010; O’Hara & Wisner, 2014).
Bipolar disorder. Characterized by fluctuation in mood or energy states that last days to
weeks at a time. While popular culture focuses on episodes of mania (increased
energy states with typically with decreased need for sleep, euphoria, impulsivity,
risk taking behavior, and grandiose thinking), people with bipolar disorder (BD)
generally spend significantly more time in a depressed state, which is often
misdiagnosed as “unipolar” depression. Women with BD are at elevated risk for
episodes during and after pregnancy with up to 50% of women with bipolar II
disorder experiencing depression postpartum (Mandelli et al., 2016).
Contributing factors include gonadal steroid withdrawal after delivery and sleep
deprivation due to circadian rhythm shifts and care needs of the newborn (O’Hara
& Wisner, 2014). Munk-Olsen et al. (2009) found that in the first 30 days
postpartum, women with BD had a relative risk of 23.3 of having a psychiatric
admission (compared to women at any other period postpartum). Pregnancy and
birth could be triggers for de novo mania and hypomania in women without
previous BD diagnoses and up to 20.4% of women experience symptoms of
hypomania after childbirth (Sharma, Al-Farayedhi, Doobay, & Baczynski, 2018).
Hypomanic, manic, and mixed episodes tend to occur immediately after childbirth
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(Sharma & Xie, 2011). The elevated mood of hypomania might be misinterpreted
as a normal joy of being a new parent and the diminished need for sleep might be
obscured by the typical sleep disruption in the postpartum period. While manic
and hypomanic episodes can occur later postpartum, depressive episodes are
much more common, affecting up to 50-75% of women with BD (Mandelli et al.,
2016).
Obsessive compulsive disorder. Mother has recurrent, intrusive, unwanted, and
uncomfortable (ego-dystonic) thoughts—often of harming self or baby. Baby is
at low risk; the mother takes steps to protect baby (possibly overprotect) and does
not want to harm it (Paschetta et al., 2014). Occurs in up to 4% of women.
Postpartum OCD is often misinterpreted as psychosis (O’Hara & Wisner, 2014).
Perinatal anxiety. Large umbrella term that includes generalized anxiety, panic, social
anxiety, and obsessive compulsive disorders. Reported rates vary with prevalence
rates from 4.5% to 15% (Paschetta et al., 2014). Prenatal anxiety is associated
with adverse outcomes including miscarriage, low birth weight, preeclampsia, and
premature birth. Prenatal anxiety is a strong predictor of postpartum depression; a
large-scale study found 66% of women meeting diagnostic criteria for a major
depressive episode in the postpartum period also had comorbid anxiety disorders
(Fairbrother et al., 2015).
Perinatal depression (often called postpartum depression). Includes profound
symptoms including dysphoria, hopelessness, helplessness, anhedonia, avolition,
crying spells, and possibly suicidal ideation. Symptoms usually begin at least
several weeks after delivery (but might be preceded by baby blues) and last at
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least two weeks. Untreated depression might persist for months or even years.
Prevalence depends on definitions; if using strict DSM 5 (APA, 2013) criteria for
major depressive disorder, Gavin et al. (2005) estimated prevalence of 7.2%
within the first three months postpartum, whereas the incidence of more broadly
defined depression was estimated at 19.2%. A study of prevalence of depression
during pregnancy estimated 18.4% with 12.7% meeting criteria for a major
depressive episode (O’Hara & Wisner, 2014), indicating prenatal depression was
just as prevalent as postnatal depression.
Postpartum psychosis. A break from reality that constitutes a medical emergency. The
mother might be confused or disoriented; she might experience hallucinations or
delusions, for example, believing her baby is possessed by a demon or that she
needs to kill the infant to “save” it. These thoughts are ego-syntonic. Symptoms
can wax and wane with periods between episodes when the mother feels and
appears normal. Preexisting BD is a risk factor for developing postpartum
psychosis; women who present with postpartum psychosis frequently meet
diagnostic criteria for bipolar depression, manic, or a mixed-state, with psychotic
features (O’Hara & Wisner, 2014). Onset is generally within the first one to two
weeks after birth and incidence is one to three per 1,000 births (Earls, 2010;
Paschetta et al., 2014). The risk of recurrence with subsequent pregnancies is
between 30% and 50% (APA, 2013).
Posttraumatic stress disorder. Develops after exposure to a traumatic event associated
with serious risk of death, injury, or threat to physical integrity. Symptomclusters include re-experiencing the event (flashbacks, intrusive memories, or
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nightmares), avoidance of reminders of trauma, negative thoughts or feelings
about the trauma, and nervous system arousal related to the trauma (APA, 2013).
Childbirth itself is frequently a risk factor for development of PTSD. Women
who experience traumatic births (requiring urgent or emergent medical
intervention) or experience medical complications during pregnancy (including
hyperemesis, preeclampsia, eclampsia, and preterm labor—especially if these
require hospitalization—are at elevated risk of PTSD in the perinatal period
(Grekin & O’Hara, 2014). Other risk factors include history of non-birth related
trauma, perceived low social support, and postpartum depressive symptoms
(Grekin & O'Hara, 2014; Khoramroudi, 2018). Postpartum PTSD prevalence
ranges from 1% to 21% in community samples and up to 43% in high-risk
samples (Khoramroudi, 2018).
Doctor of Nursing Practice Project Purpose and
Statement of Objectives
The purpose of this Doctor of Nursing Practice (DNP) scholarly project was to
develop a comprehensive guide to improve the mental health care provided to women in
Kootenai County during the perinatal period. Developing this guide required the
engagement of multiple stakeholders including OB and mental health providers, nursing
and social services staff, and administrative staff. The guide recommended the following
based on stakeholder consensus:
1.

An appropriate screening instrument

2.

Appropriate screening intervals

3.

Screening method and process for recording results in the medical record
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4.

Specific actions the clinician should take based on pre-established cutoff
scores

5.

A method for transferring care and assessing follow up once risk or
symptoms have been identified.

The final objective necessitated proposal of an integrated mental health model.
Implementation of the proposed guide and model will occur outside the scope of this
scholarly project given the significant institutional and financial investment required.
Developing the scholarly project built a foundation and framework for such a program,
served to mobilize stakeholders, and provided impetus to build a comprehensive maternal
mental health clinic at Kootenai Health.
Significance of the Doctor of Nursing Practice
Scholarly Project
The DNP degree has been promoted by the American Association of Colleges of
Nursing (AACN, 2006) as the terminal professional nursing degree. The degree was
developed in response to recommendations from the Institutes of Medicine (cited in
Moran, Burson, & Conrad, 2014) reports, Crossing the Quality Chasm and The Future of
Nursing, both of which identified the need for changes to the structure and
implementation of healthcare delivery in the United States. The intended outcome of
such restructuring was to
promote health care that is safe, effective, client-centered, timely, efficient, and
equitable; that health professionals should be educated to deliver patient-centered
care as members of an interdisciplinary team, emphasizing evidence-based
practice, quality improvement and informatics; and, that the best prepared senior
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level nurses should be in key leadership positions and participating in executive
decisions. (AACN, 2006, pp. 5-6)
The DNP scholarly project also serves as a demonstration of the student’s ability
to synthesize evidence and translate it into clinical practice. Moran et al. (2014) indicated
that when a student is developing a DNP scholarly project, the following questions
should be considered: “Is there a contribution to comprehensive quality health care? Are
there specific benefits for a group, population, community, or policy? Does the project
advance nursing practice at the local, state, and national levels?” (p. 74).
This DNP scholarly project met the majority of the criteria noted above. The
project focused on improving access to evidence-based treatment in a patient-centered
setting. Implementation of the project would improve efficiency and promote safety
while providing clinical benefits to a generally under-served population. Developing the
project required this author to assume a leadership position and to work collaboratively
with other healthcare professionals. When implemented, the initial impact would be at
the local community level but if successful, the program would hopefully be adopted
across the region and neighboring communities.
Congruence with Organization’s Strategic Plan
Kootenai Health (2018) is a 292-bed community-owned hospital in Idaho’s
northern “panhandle.” It provides services to residents of northern Idaho, eastern
Washington, and western Montana. Kootenai Health’s mission is to “improve health one
patient at a time in a friendly and professional culture committed to superior quality and
safety” (p. 1). The organization’s vision is to become “a comprehensive regional medical
center delivering superior, patient-focused care and [to] be recognized among the premier
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health care organizations in the United States” by 2020 (Kootenai Health, 2018, p. 1).
Kootenai Health received the “Baby-Friendly” designation in 2002, which indicates the
highest standard of care for mothers and babies, and recognizes the organization’s
dedication to “improving infant health through breastfeeding and other maternal-infant
care practices” (p. 1). The hospital opened a Level III NICU in 2016, reiterating their
commitment to caring for the most vulnerable babies and families.
In 2006, Kootenai Health (2018) received Magnet status designation from the
American Nurses Credentialing Center. This designation is recognized nationally as “the
gold standard” for nursing excellence; hospitals with this designation are expected to
promote a collaborative culture that values, supports, and retains nursing talent.
Support of the development and implementation of this DNP scholarly project
was congruent with Kootenai Health’s (2018) commitment to providing innovative,
evidence-based, and patient-centered care as well as supporting the professional
development of nurses.
Assumptions
Prior to and during development of this scholarly project, assumptions were made
based on direct personal observation, professional clinical experience, and
communication with stakeholders. This author became pregnant with her first child
around the time she was formulating the concept for her scholarly project. She attended
her prenatal and postpartum appointments with a provider whom she trusted, wondering
if she would receive some form of screening for depression or anxiety—she did not.
When she asked directly, her OB and her nursing staff revealed they believed mental
health was an under-recognized issue but they felt unprepared to assess, much less
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address it. As this author delved into the literature, she found her experience was fairly
typical and further discussion with obstetric, pediatric, and mental health providers in her
community confirmed they felt this was an area in need of much attention. This author
recently gave birth to her second child and was encouraged to learn that her OB’s office
provided some screening (PHQ-2 at initial prenatal visit [Kroenke et al., 2003]; PHQ-9 at
six-week postpartum visit [Kroenke et al., 2001]) but not surprised to hear that if
someone scored ‘positive’ on the screens, the offices felt unequipped to manage patients
or refer them to someone who could.
As a psychiatric provider in an acute inpatient behavioral health unit, this author
frequently cared for women experiencing postpartum depression and anxiety (and less
frequently mania and psychosis) and become frustrated to learn that (a) many of the
women either had histories of mental illness prior to pregnancy and had either
independently discontinued their psychotropic medications or had been taken off of
medications by well-meaning but poorly-informed providers or (b) had not been formally
diagnosed with mental health issues prior to pregnancy but clearly displayed signs and
symptoms that could have been addressed earlier, potentially avoiding the need for
hospitalization. Finally, this author became acutely aware of the difficulty her unit’s case
managers had finding appropriate and timely follow up for these women after hospital
discharge. Her personal and professional experiences were unfortunately consistent with
findings from across the country but she was encouraged to see a tremendous amount of
support for an initiative to improve care of this vulnerable population.
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Limitations
This project was limited in scope to developing a guide for the screening, referral,
and follow up of mood and anxiety disorders in women who were cared for prenatally by
Kootenai OBGYN providers (obstetricians and midwives). Upon evidence of support or
interest, the guide could be shared with independent obstetric and midwifery practices in
the community as well as pediatric and primary care providers. The scholarly project
entailed developing the guide and seeking consensus and approval from stakeholders.
Full implementation of a stepped care or integrated mental health model will occur
outside the timeframe of the scholarly project as it would involve hiring and onboarding
one or two clinicians to be embedded within the OB clinic, a process that would require
significant institutional investment and could take many months. The guide did not make
specific treatment recommendations (i.e., recommending specific medications or
dosages) as doing so would have vastly expanded the scope of the project. The issue of
under-recognized bipolar disorder was noted and discussed in the literature review but
ultimately screening for bipolar disorder was not specifically addressed in the guideline.
Similarly, separate instruments were not identified to screen for anxiety or psychosis. It
was felt initial efforts should focus on building basic infrastructure and screening systems
and further refinements could be completed at a later date.
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CHAPTER II
LITERATURE REVIEW
Historical Background of Perinatal Mood
and Anxiety Disorders
Disturbances in mood and sensorium in pregnant and postpartum women have
been described in the literature for more than a thousand years, beginning with
Hippocrates’ descriptions of “agitation, delirium and attacks of mania” in a woman who
had recently given birth to twins (Hanley, 2009, p. 3). Hippocrates (cited in Hanley,
2009) theorized these attacks were the result of suppressed lochial discharge flowing to
the head, consistent with his theory that four “humors” determined health and
temperament and that imbalance of said humors would result in illness. Modern
scientists proposed that what Hippocrates described in the postpartum woman was in fact
Streptococcus A infection leading to sepsis and delirium but the belief that mental
disturbances in postpartum women resulted from excess moisture endured for centuries.
The 13th century physician Trotula (cited in Hanley, 2009) wrote: “If the womb is too
moist, the brain is filled with water, and the moisture running over the eyes compels them
to involuntarily shed tears” (p. 3).
While the belief that women’s psychiatric symptoms were due to fluid imbalance
was misguided, things only got worse for women in the Middle Ages when various forms
of mental illness were attributed to the practice of witchcraft and often punished by
burning or drowning—if the accused did not first die of suicide (Tasca, 2012). Case
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studies of postpartum mental disturbances began to emerge in the 16th century. By the
mid-19th century, the French physician Jean-Etienne Esquirol compiled 92 detailed case
reports describing postpartum delirium and melancholy (Hamilton, 1962). He described
varying degrees of illness; some were severe, requiring psychiatric hospitalization, and
others were milder and could be cared for in the home. He also identified proposed
causes of the illness including heredity, “extreme susceptibility,” previous similar
episodes, emotional instability, and traumatic events (Hamilton, 1962, p. 126). These
early observations bore striking resemblance to currently recognized risk factors for
perinatal mental illness. However, Esquirol’s recommended interventions reflected
typical medical practice at the time, primarily tepid baths and purgatives (a contemporary
American psychiatrist also prescribed copious amounts of opium to reduce restlessness
and irritability; Hamilton, 1962).
Later in the 19th century, Louis-Victor Marcé (after whom the Marcé Society was
named) emerged as an authority on psychiatric illness in the perinatal period (Hamilton,
1962). He wrote extensively about more than 300 cases he had observed and categorized
symptom onset into three periods: during pregnancy, in the “puerperal period” (the first
six weeks after delivery), and the “lactational period” (more than six weeks postpartum)
(Hamilton, 1962, p. 128). His writings described “délére triste” or “sad delirium,” which
corresponded to what is currently called postpartum psychosis. Marcé might have been
the first researcher to propose a biologic basis for perinatal mental health issues, noting
illness corresponded to physical and functional changes in the female reproductive cycle
(Hamilton, 1962; Hanley, 2009).
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In the 1920s, three main theories arose to describe the etiology of perinatal mental
health issues (Hamilton, 1962). The first asserted no mental disorders were unique to
pregnant and postpartum states; the second attributed psychogenic causes to postpartum
illness; and the third suggested perinatal mental illness was influenced by physiological
changes (as Marcé had proposed almost 70 years earlier). In 1937, Kanosh and Hope
(cited in Brummelte & Galea, 2016) concluded postpartum psychiatric symptoms were
related to chemical changes that occurred a few days after birth, consistent with the
modern observation that abrupt drops in estrogen and progesterone levels after delivery
might contribute to postpartum psychiatric illness (Brummelte & Galea, 2016).
By the 1950s, dysphoria in the days after birth was discussed freely in women’s
magazines, including Ladies’ Home Journal and McCall’s. The former published a letter
from a maternity nurse calling attention to the “cruelty of maternity wards” (Held &
Rutherford, 2012, p. 112), resulting in a flood of letters from readers confirming their
own negative experiences. A phenomenon known as “third day blues” was described as
resulting from unpleasant birthing experiences in hospitals with inattentive staff,
unnecessary ‘medicalization’ of the birthing process, and disregard for the mothers’
autonomy. In response, Dr. Frank McGowan responded to rising levels of feministconsciousness with an article in McCall’s in which he assured women that brief, mild
“postnatal blues” were normal and women with more severe symptoms had underlying
psychological or characterological flaws (Held & Rutherford, 2012).
The term “postpartum depression” first appeared in a 1960 issue of Good
Housekeeping (cited in Held & Rutherford, 2012) with some acknowledgement that if
depression persisted beyond the first few days after delivery it might warrant professional
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treatment with newly emerging tranquilizer and antidepressant medications. A 1968
study of more than 300 women estimated prevalence of postpartum depression at 10.8%
(Rhodes & Segre, 2013). The impacts of PMADs on infants were noticed in the 1970s
when researchers studying the negative effects of maternal schizophrenia on children
used depressed mothers as a control group. To their surprise, similar negative effects
were noticed in both groups of children including increased risk for cognitive, motor, and
language delays (Rhodes & Segre, 2013).
Despite increasing awareness, the DSM did not acknowledge the existence of
postpartum depression until its 4th edition, which was published in 1994 (Segre & Davis,
2013). In that edition, postpartum mood disturbance was not considered a distinct
category or illness; rather, “postpartum onset” was a specifier that could be added to
episodes of mania, depression, or psychosis. This specifier remained in the subsequent
DSM-IV-Text Revision (DSM-IV-TR) and was modified to include “peripartum onset”
in the current edition of DSM-5 published in 2013 (Segre & Davis, 2013).
The early 2000s brought intensely high levels of media coverage to the issues of
perinatal mental health. In June 2001, three months after giving birth to her daughter and
suffering from severe postpartum depression and psychosis, Melanie Stokes jumped to
her death from the 12th floor of a hotel in Chicago (Postpartum Depression Alliance of
Illinois, n.d.). After her death, Melanie’s family became vocal advocates for perinatal
mental health, eventually lobbying for the Melanie Blocker Stokes MOTHERS Act.
Signed into law in March 2010, the legislation provides funding and support for research,
awareness, and treatment of perinatal mental health issues (Postpartum Depression
Alliance of Illinois, n.d.).
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The same month Melanie Stokes died, a mother in Houston, Texas, drowned her
five children in a bathtub in the midst of a postpartum psychotic episode. The Andrea
Yates case shocked the nation on multiple levels—first the disbelief that a mother could
calmly and methodically kill her small children and then the disbelief she could be tried
and potentially sentenced to death for actions carried out when suffering from a severe
mental illness (Charatan, Eaton, & Eaton, 2002). In 2002, Yates was convicted of capital
murder and sentenced to life in prison (over the objection of the prosecution who
recommended the death penalty). The conviction was later overturned and in 2006,
Yates was acquitted by reason of insanity and committed to a state psychiatric facility
(McLellan, 2006).
These highly publicized cases dramatically shifted the public narrative about
perinatal mental health. News media ran stories highlighting the prevalence and
seriousness of postpartum depression while advocates for mental health and criminal
justice reform aligned to advance awareness and shape legislation (Levin, 2016; Moran,
2002). In the mid-2000s, American celebrities began going public with their own mental
health struggles. One of the first was Brooke Shields who appeared on Oprah in 2005 to
discuss her battle with postpartum depression and to release her new memoir, Down
Came the Rain: My Journey Through Postpartum Depression. In subsequent years,
Shields was joined by Courtney Cox, Gwyneth Paltrow, Amanda Peet, Drew Barrymore,
Adelle, and other famous women who shared their experiences with postpartum
depression.
As awareness of PMADs has advanced in recent years, and so have advocacy and
legislation. In 2006, New Jersey became the first U.S. state to mandate postpartum
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depression screening; it was soon followed by Illinois, Massachusetts, and West Virginia.
Many other states have convened task forces to expand education, screening, and access
to care (Rhodes & Segre, 2013; 2020 Mom, n.d.). In 2010, the Melanie Blocker Stokes
MOTHERS Act was included in the text of the U.S. Patient Protection and Affordable
Care Act (ACA), mandating ongoing research and development of evidence-based
treatment approaches to PMADs (Postpartum Depression Alliance of Illinois, n.d.). This
legislation was unfunded but in 2016 the Bringing Postpartum Depression Out of the
Shadows Act was signed into law and allocated $5 million to states to develop and
expand treatment of PMADs (2020 Mom, n.d.).
In June of 2018, Illinois enacted new legislation that allowed postpartum mental
illness to be considered as a mitigating factor in criminal sentencing (Prokos, 2018).
While laws in the United Kingdom and Europe recognize postpartum psychosis is a
mental illness requiring treatment and rehabilitation rather than incarceration and
punishment, Illinois’ law is thus far the only one in the United States that acknowledges
or references perinatal mental illness (Prokos, 2018). Understanding of perinatal mental
health issues has progressed immensely since ancient times but there is still much work to
be done. Expanding awareness and advocacy must be translated into improved access
and treatment, which in turn must improve outcomes for women, their babies, and their
communities.
Theoretical Framework
The Stetler (2001) model was initially developed in 1976 and refined in 1994 as a
practitioner-oriented model to assist individuals and groups to translate research into
evidence-based practice. The model emphasized the importance of critical-thinking and
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acknowledged non-research related forms of information are frequently combined with
research in the decision-making process. Use of the model involved “determination of
the availability of needed resources and, if applicable, the cooperation, support, or
readiness of the stakeholders” (Stetler, 2001, p. 273). The Stetler model was used as the
theoretical framework for this DNP scholarly project because the emphasis on both
external evidence (formal studies, systematic reviews, consensus of national experts) as
well as internal factors (experiences, local consensus) allowed a valuable level of
flexibility and creativity that would facilitate implementation of a new clinical practice
that matched the needs of the providers as well as the community. The model consisted
of the following five phases:
•

Phase I: Preparation

•

Phase II: Validation

•

Phase III: Comparative Evaluation & Decision-Making

•

Phase IV: Translation/Application

•

Phase V: Evaluation

Phase I: Preparation involved use of “conscious, critical thinking,” (Stetler, 2001,
p. 275) to identify a problem, define the purpose and outcomes of a project, affirm
priorities, consider influential factors, and perform initial review of sources of
information. For this scholarly project, this phase involved informal discussion with
stakeholders, general review of related literature, and observation of community trends.
Stakeholders included local OB, pediatric, and mental health providers; nurse managers;
social workers; as well as patients who tried to navigate the system with varying degrees
of success. This phase overlapped with the author’s first pregnancy, during which time
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she was increasingly aware of the prevalence of PMADs as well as the dearth of local
resources available. This phase involved considering both external and internal factors
when determining how to obtain and assess information.
Phase II: Validation required critical evaluation of sources that would be used in
project development and implementation and synthesis of those findings. If sources of
information were not found to be valid, the process could not continue. This involved a
comprehensive literature review and discussion with national experts in the field of
perinatal mental health. Additionally, a brief survey was distributed to local stakeholders
to assess their current practice with regard to PMADs.
In Phase III: Comparative Evaluation and Decision-Making, this author assessed
substantiating evidence, fit of the setting, feasibility, and current practice in order to
guide her decision-making. While a brief survey was distributed to stakeholders during
the validation phase, this project used the Delphi method to formally solicit more detailed
feedback from OB and mental health providers in the community regarding their
perceived needs, beliefs, and barriers. A wealth of literature was available regarding the
assessment, referral, and treatment of PMADs; however, without stakeholder engagement
and without ensuring a good ‘fit’ for the target community, potential benefits of this
project would be diminished.
In Phase IV: Translation/Application, evidence received in Phase III was
translated into action. For this scholarly project, this culminated in the development of a
guide related to screening, assessment, and referral of PMADs that fit the needs of the
community (including providers, consumers, and other stakeholders). This guide took
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into account current clinical practice, workflows, perceived needs of the users, and
available community resources.
According to Stetler (2001), Phase V: Evaluation could be formal or informal and
focused on an individual or an institution. Evaluation of the effects of the guide will
occur outside the scope of this scholarly project and will involve discussion with
administration, providers, and staff, as well as chart audit and case review. Individual
impacts will be assessed through face-to-face discussion with stakeholders to gather
feedback to make ongoing refinements to the guide.
Synthesis of the Literature
An extensive and reiterative review of literature was conducted prior to and
during development of this scholarly project. The review focused on three primary
domains: (a) a review of position statements, best practices, and formal recommendations
for screening and treatment of PMADs issued by pertinent organizations (American
College of Obstetricians and Gynecologists, American Academy of Pediatrics, American
Academy of Family Physicians, U.S. Preventive Services Task Force, American
Psychiatric Association, and others); (b) a review of exemplar guidelines, algorithms, and
“toolkits” for screening and treatment of PMADs actually used in clinical practice around
the country; and (c) a review of evidence supporting the recommendations and current
practices.
The literature search included use of PubMed, Cumulative Index to nursing and
Allied Health Literature (CINAHL), GoogleScholar, the Agency for Healthcare Research
and Quality’s National Guideline Clearinghouse, and individual organizations’ webpages.
Keywords included perinatal, pregnancy, postpartum, depression, anxiety, mood disorder,
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psychosis, mental health, screening, treatment, referral, system, guideline, algorithm,
toolkit, referral, and system.
Professional Organization Recommendation:
American College of Obstetricians
and Gynecologists
In a committee opinion published in May, 2015 (reaffirmed in 2016 and updated
in 2018), the American College of Obstetricians and Gynecologists (ACOG)
recommended that “clinicians screen patients at least once during the perinatal period for
depression and anxiety symptoms using a standardized, validated tool” (p. e208). The
opinion noted perinatal depression and anxiety were among the most common
complications of pregnancy and if untreated could have significant negative impacts on
women, their infants, and their families. The ACOG opinion noted that identifying
women during the perinatal period might help to mitigate potentially devastating effects:
“There is evidence that screening alone can have clinical benefits, although initiation of
treatment or referral to mental health care providers offers maximum benefit” (p. e208).1
The committee advised that OB providers and clinical staff be poised to initiate treatment
and refer the patient to appropriate behavioral health resources if indicated. These
resources were not described and the opinion simply stated, “Systems should be in place
to ensure follow-up for diagnosis and treatment” (ACOG, 2018, p. e208).
In 2018, ACOG published a “Postpartum Toolkit,” developed by a task force
dedicated to “redefining the concept of the postpartum visit by reevaluating the timing
1

The November 2018 update to the ACOG recommendation cited meta-analyses
commissioned by the USPSTF (O’Connor, Rossom, Henninger, Groom, & Burda, 2016;
Siu, 2016) as evidence that screening alone might improve outcomes; however, in-depth
review of those documents in fact indicated there was no evidence that screening alone
improved outcomes. The authors specifically noted these studies did not separate women
who received screening alone from women who received treatment and screening.
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and content of postpartum care” (p. 1). This toolkit included information,
recommendations, and resources focused on improving the quality and
comprehensiveness of postpartum care across multiple domains including pregnancy
complications, preventative care, vaccinations, weight management, reproductive
planning, substance use, breastfeeding, and depression. A section on postpartum
depression discussed incidence, risk factors, signs and symptoms, screening instruments,
treatment, and referral resources.
Screening timing and interval. The ACOG (2016) opinion was relatively vague
in terms of when screening should be completed, specifying only “at least once during
the perinatal period” (p. 1). This period included pregnancy and the first 12 months
postpartum. The opinion noted that if a woman screened positive for depression or
anxiety during pregnancy, additional screening should be completed during the
comprehensive postpartum visit. The postpartum toolkit (ACOG, 2018) did not make
any specific recommendations regarding depression screening intervals but generally
recommended all postpartum women see their providers within three weeks after delivery
and again no later than 12 weeks postpartum.
Screening tools. The ACOG (2016) opinion did not specifically endorse use of
any one screening tool but outlined the pros and cons of several tools that had been
validated for use during pregnancy. The opinion listed seven tools: the Edinburgh
Postnatal Depression Screen (EPDS), Postpartum Depression Screening Scale (PDSS),
PHQ-9, and several others (ACOG, 2016). The EPDS was discussed most extensively
and was recommended over the other tools in part because it assessed anxiety and
excluded somatic symptoms that are normal in the postpartum period. It was noted the
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screening tools were not diagnostic and results must be interpreted with clinical judgment
and consideration to context.
In the ACOG (2018) toolkit under the subheading “Screening and Diagnosis,”
seven different screening instruments were listed in bullet-point format (including the
EPDS, PDSS, and PHQ-9, Beck Depression Inventory I and II, and others).
Beyond screening. In the original 2015 opinion and the 2016 revision, ACOG
acknowledged that screening alone would not improve clinical outcomes and must be
paired with appropriate treatment and follow up. This might include initiation of medical
therapy by the OB provider and/or referral to other appropriate resources. The use of
collaborative care, including use of a “depression care manager,” (suggested to be a nurse
or social worker) possibly even within the OB office, is suggested, though no further
guidance is issued in the committee opinion.
In the postpartum toolkit (ACOG, 2018), the subheading “Treatment” lists peer
counseling, cognitive behavioral therapy, and antidepressants, and the subheading
“Anticipatory Guidance and Follow-up” recommends encouragement, support, and
referral to a behavioral health specialist in cases of suicidal ideation, severe symptoms, or
bipolar disorder. As of February, 2018, the toolkit echoed the previous ACOG (2016)
committee opinion that screening alone did not improve clinical outcomes and it was
imperative that providers promptly refer patients to appropriate mental health resources
when appropriate (ACOG, 2018).
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U.S. Preventive Services Task Force
Recommendation Statement:
Screening for Depression
in Adults
In 2016, the USPSTF (Siu, 2016) published an updated statement on screening for
depression in adults, recommending “screening for depression in the general adult
population, including pregnant and postpartum women. …Screening should be
implemented with adequate systems in place to ensure accurate diagnosis, effective
treatment, and appropriate follow-up” (p. 380). Convincing evidence indicated screening
improved identification of depression in primary care settings and subsequent treatment
with psychotherapy, antidepressants, or a combination of both improved clinical
outcomes. The USPSTF’s review of fair or good quality trials found 28%-59%
reductions in risk of depression in postpartum women who received screening and some
form of follow-up as compared to care-as-usual (Siu, 2016).
Adequate evidence was found that the magnitude of harms for screening of
depression across the adult population was small to none (Siu, 2016). The magnitude of
harms for treatment of depression in pregnant and postpartum women with cognitive
behavioral therapy was small to none and the magnitude of harms related to treatment
with second-generation antidepressants in this population was determined to be small to
moderate, taking into consideration the low, but potential risk of fetal harm from
medications (Siu, 2016, p. 381). The recommendation was rated as Level B, with a level
of certainty regarding net benefit rated as “moderate.” The USPSTF (Siu, 2016)
concluded there was a moderate net benefit to screening for depression in adults,
including pregnant and postpartum women if there were “adequate systems in place to
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ensure accurate diagnosis, effective treatment, and appropriate follow-up after screening”
(Siu, 2016, p. 381).
Screening timing and interval. The USPSTF (Siu, 2016) recommendation noted
limited information was available regarding the optimal timing and frequency of
screening for depression in pregnant and postpartum women. In light of limited
evidence, it was recommended to use a “pragmatic approach,” to consider screening all
adults who have not been previously screened, and to use clinical judgment to screen
individuals with risk factors or presentations that raise suspicion of depressive disorders
(Siu, 2016, p. 382).
Screening tools. The USPSTF (Siu, 2016) did not specifically recommend any
one screening tool but identified the EPDS as a commonly used and validated instrument
for screening pregnant and postpartum women. The USPSTF reviewed 23 studies of the
accuracy of the EPDS and found sensitivity ranging from 0.67 (95% CI, 0.18-0.96) to
1.00 (95% CI, 0.67-1.00). Specificity for detecting major depressive disorder (MDD)
across the studies was at least 0.90 (Siu, 2016, p. 384).
Beyond screening. The USPSTF (Siu, 2016) specifically recommended that
“screening should be implemented with adequate systems in place to ensure accurate
diagnosis, effective treatment, and appropriate follow-up”; the statement expanded on
this recommendation, specifying the “appropriate systems and clinical staff must ensure
(1) screening is conducted; (2) if screens are positive, patients are either appropriately
diagnosed and treated in that clinical setting, or referred to the appropriate setting for
follow-up” (p. 383). The USPSTF recommendation acknowledged these systems could
take a variety of forms. The lowest effective level of support was described as a system in
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which a designated nurse advised physicians of positive screen results and implemented a
protocol to refer the patient to appropriate follow-up. The other end of the spectrum, the
highest level of support involved providing educational workshops to clinical and support
staff, providing ongoing monthly educational lectures, clinician manuals, printed
educational materials for providers, staff, and patients; personalized visits with a nurse
specialist in which the patient receives assessment, education, and ongoing support; and
visits with a therapist trained in cognitive behavioral therapy (Siu, 2016, p. 383).
Recommendation Statement:
American Academy of
Pediatrics
The AAP (Earls, 2010) recognized that perinatal depression was “the most
underdiagnosed obstetric complication in America” (p. 1032) and pediatric providers
were ideally positioned to facilitate early detection and intervention that could minimize
negative outcomes for the infant, mother, and family unit. In 2010, the AAP published a
clinical report entitled, Incorporating Recognition and Management of Perinatal and
Postpartum Depression into Pediatric Practice (Earls, 2010). The report offered a
review of pertinent literature and made recommendations regarding screening, treatment,
and referral of perinatal depression. The report also specified which current procedural
terminology (CPT) code should be used for screening to facilitate reimbursement. The
recommendations were drawn largely from the Surgeon General’s Conference of
Children’s Mental Health report (U.S. Department of Health and Human Services, 2000),
USPSTF recommendations (Siu, 2016), and the AAP’s own Bright Futures guidelines,
which provided a suggested schedule of screenings for preventive pediatric health care
(Earls, 2010).
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The AAP report (Earls, 2010) recognized that while the infant, not the mother,
was the pediatric provider’s patient, supporting the mother and ensuring timely
assessment and referral to appropriate resources would positively impact the entire family
system. Because the pediatric care provider might have the most regular and frequent
contact with the mother/family after birth, they were in an optimal position to provide
early screening and facilitate intervention (Earls, 2010).
Screening timing and interval. The AAP (Earls, 2010) recommended screening
at the one-, two-, four-, and six-month visits based on statistical peaks in onset of
postpartum depression at six weeks, two to three months, and six months after
delivery. Screening was not specifically recommended at a prenatal visit but the report
noted this could be an ideal opportunity to identify risk factors and anticipate care
needs. The report recommended using CPT code 99420 for screening, indicating this
assessed a measure of risk in the child’s environment. This CPT code has since been
deleted and replaced with code 96161, indicating “administration of caregiver-focused
health risk assessment instrument (e.g., depression inventory) for the benefit of the
patient, with scoring and documentation, per standardized instrument” (AAP News,
2016).
Screening tools. The AAP (Earls, 2010) recommended using either the EPDS
(Mcbride et al., 2014) or the PHQ-2 (Kroenke et al., 2003). It should be noted the AAP
report was published in 2010 and based on the USPSTF 2002 depression screening
recommendations, which have since been updated and specifically recommend use of the
EPDS in perinatal women and the PHQ (various forms) in the general adult population
(USPSTF, 2018).
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Beyond screening. The AAP (Earls, 2010) recognized symptoms and illness
exist on a continuum and responses to positive screens should be appropriately tailored to
the individual and situation. Reassurance and education might be the most appropriate
response to milder symptoms, whereas moderate or severe symptoms might require
referral to another provider including obstetric, primary care, or mental health
providers. If there was any indication of psychosis or suicidality or if the EPDS (Mcbride
et al., 2014) score was greater than 20, the AAP recommended “using the referral process
for local public mental health crisis/emergency services” (Earls, 2010, p. 1036). The
report recommended considering referral to a variety of community-based programs
including Early Head Start, Mother’s Morning Out, or the Nurse-Family Partnership. No
guidance was provided regarding use of psychotropic medications or specific forms of
psychotherapy.
Recommendation Statement:
Postpartum Support
International
Postpartum Support International (PSI, 2019a) is an organization founded in 1987
with the purpose of increasing “awareness among public and professional communities
about the emotional changes that women experience during pregnancy and postpartum”
(p. 1). The organization advocates for research and legislation to support perinatal
mental health and provides printed and electronic educational materials, online support
groups, a toll-free warm-line, and comprehensive training for health systems, support
group leaders, clinicians, and volunteers. Postpartum Support International maintains a
section on their website with up-to-date recommendations for screening, treatment, and
referral of PMADs.
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Screening timing and interval. Postpartum Support International (2019b)
recommends screening (a) at the first prenatal visit, (b) at least once in the second
trimester, (c) at least once in the third trimester, (d) at the first or the six-week postpartum
OB visit, and (e) at 6- or 12- months postpartum either in the OB or primary care
settings. Additionally, PSI recommends screening be performed at the 3-, 9-, and 12month pediatric visits.
Screening tools. Postpartum Support International (2019b) recommends use of
the EPDS (Mcbride et al., 2014) or the PHQ-9 (Kroenke et al., 2001) with 10 being a
recommended cut-off score for a positive screen using either tool. Postpartum Support
International also notes the EPDS is a reliable screening tool for fathers but requires a
lower cut-off for a positive score (recommended to use 5 or 6 to determine a ‘positive
screen’). It is recommended the screening be provided in the patient’s native language if
possible, in a private setting, and be introduced in a “caring and informative manner that
normalizes perinatal mental health needs” (PSI, 2019a, p. 1).
Beyond screening. Postpartum Support International’s (2019b)
recommendations note that screening must be performed within a system that provides
appropriate providers, supports, and an established protocol for referral for followup. The organization actively supports such systems by providing education to patients
and clinicians, maintaining provider directories to facilitate referrals, and advocating for
improved systems at community and state levels (PSI, 2019b).
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Recommendation Statement: Department
of Veteran Affairs/Department
of Defense
The Department of Veteran Affairs and Department of Defense (Veterans Affairs,
2016) published an updated clinical practice guideline for management of pregnancy in
2018. New to this update (since 2009) is the recommendation that pregnant women be
screened for depression during pregnancy and postpartum. This guideline was accessed
through the Agency for Healthcare Research and Quality (2018), which has scored the
guideline as “excellent.”
Screening timing and interval. According to the VA/DoD guideline, screening
for depression was recommended “periodically during pregnancy and postpartum”
(Veterans Affairs, 2016, p. 21). No further recommendations were given regarding
timing for frequency.
Screening tools. The VA/DoD (Veterans Affairs, 2016) guideline recommended
using the EPDS (Mcbride et al., 2014) or PHQ-9 (Kroenke et al., 2001).
Beyond screening. There was no discussion in the VA/DoD (Veterans Affairs,
2016) guideline about further evaluation, referral, or treatment of depression in pregnant
or postpartum women. Potential harms of screening included time spent screening and
possible discomfort with screening questions.
Recommendation Statement: Marcé
Society for Perinatal
Mental Health
The Marcé Society (2019) was formed in England in 1980 and its stated aim was
to “promote, facilitate and communicate about research into all aspects of the mental
health of women, their infants and partners around the time of childbirth” (para. 2). In

41
2013, the Society published a position statement on psychosocial assessment and
depression screening in perinatal women that discussed arguments for and against
universal psychosocial assessment and depression screening (Austin, 2014). The
statement outlined general principles involved in this work but explicitly avoided making
specific recommendations regarding tools, instruments, or systems to facilitate such
screening, instead stating, “These will need to be devised locally depending on existing
resources and models of care” (Austin, 2014, p. 179). The position statement included a
bullet-pointed list of “Guiding Principles” and suggested these be considered when
providing psychosocial assessment and depression screening. These were fairly broad,
non-specific recommendations (Austin, 2014).
Screening timing and interval. The Marcé Society’s position statement
suggested screening be completed during pregnancy and “at an appropriate time
postpartum (e.g., 3 months)” (Austin, 2014, p. 185). No further or more specific
recommendations were made.
Screening tools. The Marcé Society (Austin, 2014) did not endorse use of any
one screening tool or instrument. The EPDS (Mcbride et al., 2014) was briefly
mentioned and the statement noted Australian guidelines recommended universal use of
the EPDS within integrated screening programs. Scottish and British guidelines
suggested the EPDS be used only as an adjunct to clinical practice and also mentioned
use of the Whooley Questions—a two-question depression-screening tool very similar to
the PHQ-2 (Austin, 2014).
Beyond screening. The Marcé Society (Austin, 2014) emphasized the
importance of psychosocial assessment that involved evaluating multiple domains, which
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could impact a woman’s mental health including social, cultural, psychological, and
biological risk factors. Such assessment is generally completed through clinical
interview and, in addition to identifying risk factors, could serve as a way of establishing
a trusting relationship between the woman and her provider and providing an opportunity
for education (Austin, 2014).
The Marcé Society’s (Austin, 2014) position statement emphasized a
collaboration between providers and professions to improve care with appropriate referral
by the primary care provider to a specialist when indicated. These systems should take
the mothers’ preferences into consideration and respect her personal and cultural needs
(Austin, 2014). Table 1 provides more information regarding professional organization
recommendations for PMAD screening.
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Table 1
Professional Organization Recommendations for Perinatal Mood and Anxiety Disorders
Screening
Organization,
Year
Published
ACOG, 2018

Disorders
Addressed

Tool
Recommended

Screening
Frequency

Systems

Comments

Depression
and anxiety

Standardized,
validated. Ranks
7 tools
preferentially;
EDPS is first

Once during
perinatal period,
If positive screen
during
pregnancy, repeat
screen
postpartum

Appropriate follow
up and treatment. No
specific guidance,
discussion of
collaborative care and
depression care
manager

USPSTF,
2018

Depression

Does not
specifically
recommend a
single tool;
identifies EPDS
as commonly used
and validated

Pragmatic
approach.
Consider
screening all who
have not been
previously
screened; use
clinical judgment
if risk factors,
signs or
symptoms

Adequate systems in
place to ensure
accurate diagnosis,
effective treatment,
and appropriate
follow-up. Stepped
care, ranging from
designated nurse who
alerts provider and
implements protocol
for referral, to
intensive and ongoing
training of clinical
and support staff

AAP

Perinatal
depression.
Brief
discussion
of
psychosis

EDPS, PHQ-2

Infant’s 1-, 2-, 4-,
6-month visits

Recommends
familiarity with local
resources, especially
for psychosocial
support and
emergencies; no
discussion of formal
referral systems.
Consider communitybased programs:
Early Head Start,
Mother’s Morning
Out, Nurse Family
Partnership

CPT code 99420
for screening
(code has since
been updated to
96161). Referral
to crisis/
emergency
services if
psychosis,
suicidality, or
EPDS >20.

PSI, 2019a

Mood and
anxiety
disorders

EPDS or PHQ-9,
with cutoff of 10
as recommended
for positive
screen.

First prenatal
visit, at least
once in second
trimester, at least
once in third
trimester, at first
or 6-week
postpartum OB
visit, at 6-and 12months
postpartum, at 3-,
9-, and 12-month
pediatric visits

Emphasizes
development of
established protocol
for referral and follow
up. Encourages use
of community
resources.

Organization is
actively involved
in advocacy work,
provider
directories/referral
systems, warmline for patients,
and consultation
services for
providers.
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Table 1 continued
Organization, Disorders
Year
Addressed
Published
VA/DoD,
Depression
2018
Marcé
Society,
2019

Depression

Tool
Recommended

Screening
Frequency

Systems

EPDS or PHQ-9

Periodically
during pregnancy
and postpartum.

No recommendations

Does not
specifically
recommend a
single tool;
identifies EPDS
as commonly used
and validated

During
pregnancy and at
an appropriate
time postpartum.

Recommends
collaboration between
primary care and
specialists.

Comments

Emphasizes
importance of
psychosocial
assessment to
identify risk
factors for
depression and to
provide education
and rapport
building.

Established Protocols/Systems for Screening,
Referral, Treatment, and Follow Up
Through the literature review process, several protocols and algorithms pertaining
to screening, referral, and treatment of PMADs were identified. Algorithms were
included for review if they met the following criteria: included specific recommendations
for which screening tool to use and when to perform screening, included cut-off values
for ‘positive’ screens, and outlined specific steps for referral based on scores. This was
not an exhaustive review of protocols; some identified were similar to the ones detailed in
the following paragraphs. The protocols reviewed were chosen for inclusion in this
literature review because they are comprehensive and innovative, are widely utilized, and
are supported by research, respectively.
University of North Carolina
School of Medicine
The University of North Carolina (UNC, 2016) has developed one of the few
inpatient perinatal psychiatry units in the United States. In addition to the inpatient
program, the Department of Psychiatry offers a Perinatal Mood Disorders Clinic
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(PMDC), offering outpatient treatment including psychotherapy, medication
management, and a perinatal support group. The program’s founders developed a
comprehensive perinatal depression screening and treatment algorithm that is used
throughout the University’s healthcare system.
Overview of process. Screening is performed at initial OB, prenatal 28-32
weeks, lactation problem, and postpartum visits (UNC, 2016). A nurse or medical
assistant gives the patient a paper copy of the EPDS (Mcbride et al., 2014) in the
appropriate language and the patient fills it out independently. The nurse or medical
assistant then enters the patient’s responses into an EPDS flowsheet in the EPIC
electronic medical record (EMR), and the provider then reviews these answers, follows
up on any positive answers, and assesses the patient for safety (with special attention to
question #10, which asks about thoughts of self-harm). Subsequent actions are
determined by the EPDS score in conjunction with clinical judgment. All EPDS scores,
assessments, and treatment plans are documented in the EMR (UNC, 2016).
Scoring and follow-up. Scores of =<6 generally prompt supportive counseling
and encouragement to reach out to the provider should symptoms change. For scores of
6-9, the recommendation is to follow up at future visits, repeat EPDS screening if there is
any indication of symptoms, and to provide printed material about the PMDC (UNC,
2016).
Scores of 10-12 indicate concern for minor depression and the provider is
prompted to discuss stress relief, coping strategies, self-care, and sleep hygiene (UNC,
2016). An ICD9 code of 648.4 (“elevated EPDS”) is added to the patient’s problem list
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(WHO, 2018). The patient is provided with printed material about the PMDC and follow
up is conducted at future visits with repeat EPDS if there is any indication of symptoms.
Scores of =>12 indicate concern for major depression and further clinical
assessment is indicated (UNC, 2016). If, after discussion, the clinician is not alarmed
about the patient’s psychiatric situation or if there is no intent or plan for self-harm, the
patient is offered counseling, medications, and referral for outpatient psychiatric
evaluation. The patient is also provided with the interventions provided for patient with
scores of 10-12.
If the clinician IS alarmed by the patient’s presentation or if there is any intent or
plan for self-harm, the clinician pages one of the PMDC psychiatric providers
(psychiatrists or psychiatric nurse practitioners) to discuss a plan of care (UNC, 2016). If
there is concern for immediate harm to self or others, the patient is escorted to the nearest
emergency department for evaluation.
Massachusetts Child Psychiatry
Access Project
The Massachusetts Child Psychiatry Access Project (MCPAP, 2015) is a network
of behavioral health consultation teams that provides support to primary care providers
and facilitates integration of behavioral health into the primary care setting. The MCPAP
developed a downloadable toolkit, the MCPAP for Moms Toolkit, to help providers
implement screening into their pediatric visits as well as provide education, prompts, and
suggestions for providers. Included in the toolkit are a primer with background
information about the prevalence, risk, and potential complications of PMADs as well as
available treatment options, a screening algorithm with suggested talking points, PDFs of
the EPDS (Mcbride et al., 2014) and PHQ-9 (Kroenke et al., 2001), and PDFs of
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checklists that incorporate EPDS questions into comprehensive well-child assessments
for specific age groups (MCPAP, 2015). The toolkit also includes a handout with clinical
pearls that can help a provider assess levels of risk and a summary of PMADs including
Baby Blues, perinatal anxiety, perinatal depression, PTSD, OCD, and postpartum
psychosis. Finally, the toolkit provides information about resources available in
Massachusetts including emergency services, expedited referral to mental health
providers, and home visitation programs (MCPAP, 2015).
Overview of process. Postpartum depression screening is completed during
well-child visits within the first month after birth, at the two-, four-, and six-month visits,
and at other visits if indicated (MCPAP, 2015). The recommended screening tool is the
Survey of Wellbeing of Young Children (SWYC; Tufts Medical Center, 2019), which is
described as “a comprehensive screening instrument used to assess children’s cognitive,
language, motor, and social-emotional development as well as family risk factors” (para.
1). The SWYC is provided in versions specifically tailored to the two-, four-, and sixmonth visits with the original EPDS (Mcbride et al., 2014) embedded in each version.
Clinical support staff explains the screen to the parent at the time of the first
screening, and the parent self-completes the SWYC in a waiting room or private exam
room. The MCAPA toolkit instructs the provider to document a clinical plan based on
screening results but notes the screen itself is not required to be included as part of the
medical record. The provider might bill for screening (using the SWYC with embedded
EPDS [Mcbride et al., 2014], or the standalone EPDS) using the developmentalbehavioral procedure code 96110 (WHO, 2018).
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Scoring and follow-up. An EPDS (Mcbride et al., 2014) score of <10 is
considered to not suggest depression, and clinical staff provide the parent with
information about community resources to support emotional wellness (MCPAP, 2015).
An EPDS score of ≥10 is considered to be a positive screen and further steps are based on
clinical assessments of safety and risk. If there is any indicated risk of self-harm or
suicide, immediate further assessment is indicated; talking points and assessment
questions are provided in the screening algorithm. The parent/baby are not to be left
unattended until further assessment and treatment plans have been established. The
provider is instructed to call the MCPAP (2015) regional hub with any clinical questions
and to refer to emergency services for any safety concerns.
For positive screens without concern for self-harm or suicide and if the patient is
currently or previously engaged in mental health treatment, they should be referred back
to their mental health provider and the provider should be notified of the positive screen
(with the patient’s consent). If the parent is not already engaged in mental health
treatment, the provider can contact a MCPAP for Moms care coordinator for community
referral resources and referral information. The parent’s primary care provider (PCP)
and/or OBGYN should also be notified of the need for monitoring and follow-up.
Throughout this process, the pediatric provider can provide the parent with supportive
counseling and encouragement (MCPAP, 2015).
The Women’s Place-Texas
Children’s Hospital
The Women’s Place is reproductive psychiatry program at the Texas Children’s
Hospital (affiliated with Baylor College of Medicine) in Houston, Texas, that provides
psychiatric and psychological services for women across the reproductive lifespan
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including preconception, during pregnancy, postpartum, and through menopause
(Puryear, 2018). The program has recognized the need for enhanced detection, referral,
and treatment of perinatal mental health issues in primary care, noting there are not
enough mental health specialists to treat all those who need help. The program also notes
that while screening recommendations and legislation are an important first step, it is
imperative that appropriate systems be developed for follow-up, treatment, and ongoing
support in the community. Using funding provided through the Texas Delivery System
Reform Incentive Payment program, researchers and providers at The Women’s Place
developed a pilot project with the goal to increase access and improve the early detection
and treatment of perinatal mental health (Puryear, 2018). The team surveyed primary
care providers (pediatric and OB) and found common barriers to screening and
assessment of perinatal mental health issues included lack of adequate mental health
referral destinations, fear that screening meant ‘ownership’ of the problem, and lack of
time and reimbursement. Additional challenges faced by pediatric providers included
overcoming new mothers’ fear of Child Protective Services (CPS) involvement should
she disclose any symptoms of mental illness or thoughts of harming herself or her baby
(Puryear, 2018).
Through this pilot program, The Women’s Place team provided one-hour
trainings to providers and clinical staff in pediatric and OB practices focused on the signs
and symptoms of PMADs, administration and scoring of the EPDS, and documentation
and submission of electronic referrals through the electronic medical record (Puryear,
2018). The team provided ongoing consultation, education, and support for the pediatric
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and OB providers as well as analysis of rates of screening, referrals, and completed
follow-ups.
Of very high interest, data analysis showed significant differences in follow-up
completion depending on the location of the mental health provider (Puryear, 2018). In
“coordinated referral” or referral to a mental health provider in a separate, distinct
location, the rate of completed appointments was only 21.1% (Puryear, 2018). When
mental health services were co-located (affiliated with the primary care office, within the
same building or floor but in a separate office), the completion rate was 75.7% and when
mental health was coordinated (an embedded provider within the primary care office), the
completion rate was 81.1% (Puryear, 2018).
Overview of process. The OB providers performed depression screening during
pregnancy at the first prenatal visit, between 34-36 weeks gestation, and at six weeks
postpartum (Puryear, 2018). Pediatric providers performed screening at the initial wellchild visit around two weeks, and two-, four-, and six-month well-child visits. In both
settings, the mother self-completed the EPDS (Mcbride et al., 2014), which was scored
by staff. Scores and treatment plans ere documented electronically in the EPIC EMR
(Puryear, 2018).
Scoring and follow-up. If a score was =>10, the physician was to be notified and
would discuss the results, referral, and treatment options with the mother (Puryear,
2018). If the mother agreed to the referral, an electronic referral was sent to The
Women’s Place or another appropriate resource. If the mother did not agree to the
referral, this was documented in EPIC. There was no specific process for ongoing
follow-up or assessment outlined in the High-Level Process Map detailing the screening
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and referral process but during a conference presentation of this initiative, the importance
of an integrated, comprehensive care network was emphasized (Puryear, 2018). Such a
system would include culturally appropriate interventions, peer support, social work,
emergency services, home visit, phone outreach, and a mobile van/clinic that could
provide services in a woman’s community. Table 2 provides detailed information
regarding the aforementioned clinical protocols for assessment and referrals of patients
with perinatal mood and anxiety disorders.
Table 2
Clinical Protocols for Assessment and Referral of Patients with Perinatal Mood and
Anxiety Disorders
Institution

Tool Used

Location

Timing

Cut-off
Values
0-5: no
6-9:
mild
10-12:
moderate
>12: major

Direction for Urgent
Intervention
Clinical assessment,
contact designated
psychiatric provider by
pager to discuss care plan;
if immediate potential for
harm: escort patient to
nearest ED

UNC

EPDS

OB offices

Initial OB, prenatal
28-32 week,
lactation problem,
postpartum visit

MCPAP

EPDS
(embedded
in SWYC)

Peds offices

Initial well-child
visit within first
month; then 2-,4-,6month appointments,
or if indicated

=>10:
positive
screen

Emergency services if
acute concern for harm to
self/others; contact
MCPAP regional hub with
clinical concerns

The
Women’s
Place

EPDS

OB, peds
offices

OB: initial OB, 3436 weeks gestation,
6 weeks postpartum.
Peds: 2 week follow
up, 2-,4-, 6-month
follow up

=>10:
positive
screen

Referral to “appropriate
resource”

Evidence for Perinatal Mood and
Anxiety Disorders Screening
Conflicting evidence exists related to universal screening for depression in
pregnant and postpartum women. A systematic review completed by Thombs et al.
(2014) concluded, “There is currently no evidence from any well-designed and conducted
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[randomized control trial] that screening for depression would benefit women in
pregnancy or postpartum” (p. 433). The authors recommended current screening
guidelines be reconsidered until quality, randomized control trials could be completed.
They further recommended healthcare providers educate women and their families about
depression and that providers be alert for signs or symptoms of depression in pregnant or
postpartum women and provide appropriate “assessment, […] referral or management”
(Thombs et al., 2014, p. 439).
In their recent systematic review of evidence around screening for perinatal mood
and anxiety disorders, Long, Cramer, Jenkins, Bennington, and Paulson (2018) asserted
providers too often relied on clinical judgment rather than standardized assessment,
which could lead to under-recognition of potentially serious illness. They recommended,
“Given the prevalence and negative impacts of PMAD on mothers and children, further
interventions to improve screening and referral are needed” (Long et al., 2018, p. 25).
A USPSTF commissioned systematic review of evidence published in 2016 by
Siu found sufficient evidence to support universal screening of pregnant and postpartum
women. The systematic review found 28-59% reductions in risk of depression at the
three- to five-month follow up in women who participated in screening programs.
However, the study did not differentiate between studies in which women received
screening alone versus screening and additional treatment (Siu, 2016).
In January of 2019, a group of researchers in Canada conducted a systematic
review to evaluate the evidence around screening for depression in pregnant and
postpartum women but it was unknown when this study would be completed (Hamel et
al., 2019). In light of the limited and sometimes conflicting data, it might be appropriate
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to take a more pragmatic approach when considering whether or not it is appropriate to
screen pregnant and postpartum women for PMADs. Milgrom and Gemmill (2014)
suggested, “If a health condition is serious, prevalent, under-detected and treatable, and if
a tolerable screening procedure of known accuracy is available, then screening can be an
effective measure in principle” (p. 14). In the case of perinatal mental health issues, these
five criteria are satisfied.
Seriousness
Perinatal mood and anxiety disorders have been associated with significant
morbidity and mortality. In the United States, postpartum women are more like to die
from suicide than from either hemorrhage or hypertensive disorders (Palladino et al.,
2011). Grigoriadis et al. (2017) found at least 1 in 19 maternal deaths in Ontario, Canada
were attributable to suicide and it was noted that the actual incidence might be
significantly higher due to underreporting of postpartum status on death certificates.
Even when the outcome is not death, PMADs severely impact the mother, infant, partner,
extended family, and community. Women are at risk for poor self-care, preterm delivery,
feelings of shame and worthlessness, and suicide (Hanley & Oberlander, 2014). Infants
are at risk for complications including low birth weight, difficulty with sleep, and
cognitive deficits that might persist into adolescence or beyond (Glover, 2014). Un- and
undertreated PMADs might interfere with the mother’s ability to form a healthy
relationship with her new baby and to maintain relationships with partners and family
members (Seymour et al., 2014).
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Prevalence
Estimates of the prevalence of postpartum depression have ranged from 7.2% to
19.2% (Gavin et al., 2005; O’Hara & Wisner, 2014) and depression during pregnancy is
estimated to be almost as common. Clinically significant anxiety affects up to 15% of
pregnant and postpartum women (Paschetta et al., 2014) and up to 43% of women in
high-risk groups might experience PTSD symptoms (Khoramroudi, 2018). Merrill et al.
(2015) commented the background prevalence of bipolar disorder in perinatal women (26%) is similar to that of gestational diabetes (5%) and gestational hypertension (4.4%),
for which both are routinely screened. Up to 70% of women with BD experience
perinatal depressive symptoms (Merrill et al., 2015)
Under-Detected
Many experts believe the numbers above might be artificially low as many
women experiencing PMADs do not independently seek treatment (Milgrom & Gemmill,
2014). Beck and Gable (2001) and Cox et al. (2016) estimated up to 50% of all cases of
perinatal depression go undetected and approximately 85% of affected women do not
receive treatment. Furthermore, it was estimated only 3-5% of affected received
adequate treatment that resulted in symptom remission (Cox et al., 2016). Barriers to
detection included lack of awareness about PMADS and available treatment, stigma,
unrealistic expectations about parenting roles and fear of being perceived as a failure, and
lack of appropriate resources or ability to navigate the mental healthcare system. The
neurogevative symptoms of PMADs including anergia, avolition, impaired concentration,
and low self-worth can feel insurmountable and can interfere with a woman’s ability to
advocate for her needs and seek treatment.
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Treatable
Extensive literature supports the effectiveness of pharmacological and nonpharmacological interventions for PMADs. Cognitive behavioral therapy, supportive
psychotherapy, brief dynamic psychotherapy, and interpersonal therapy were identified
as effective modalities (Cox et al., 2016).
Evidence for Screening Tools
The screening tools most commonly used in perinatal women include the EPDS
(Mcbride et al., 2014), the PDSS (Tatano Beck & Gable, 2002) and the PHQ-9 (Kroenke
et al., 2001). Each has been validated to some degree for use in the perinatal population;
provider or organizational preference might largely influence their use in clinical
practice. The Mood Disorder Questionnaire (MDQ; Hirschfeld, 2002) is widely used to
screen for BD in the general population and in recent years, evidence has emerged
supporting its use in perinatal women. The tools are described followed by a review of
the literature pertaining to their use.
Edinburgh Postnatal Depression
Screen
The EPDS (Mcbride et al., 2014) is one of the most broadly used, most widely
validated screening tools for depression in the perinatal period. This brief, selfadministered screen was developed in 1987 by researchers in Scotland who recognized
that existing depression screening scales did not adequately assess depression in
postpartum women (Mcbride et al., 2014). The primary deficit in existing depressionscreening scales was they included somatic symptoms that could suggest depression in
the regular population but occurred naturally and non-pathologically in postpartum
women (i.e., changes in sleep or appetite). Additionally, the existing scales were rather
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extensive and time-consuming, whereas the EPDS could be completed and scored in
approximately five minutes and scoring did not require specialized training in mental
health issues. The EPDS was developed by integrating questions selected from existing
scales (the Irritability Depression and Anxiety Scale, the Hospital Anxiety and
Depression Scale, and the Anxiety and Depression Scale of Bedford and Foulds) with
questions developed specifically by Mcbride et al. (2014). Extensive testing on mothers
with young babies helped refine the scale into a 10-item, self-administered scale that has
been widely validated for assessment of postpartum and antenatal depression (Mcbride et
al., 2014).
The EPDS (Mcbride et al., 2014) consists of 10 items in which subjects are asked
to rate their symptoms in the previous seven days on a scale of 0-3 (0 = Not at all, 1 =
Not very often, 2 = Most of the time, 3 = All of the time). Questions are related to
emotional symptoms and specifically exclude somatic symptoms common to many
women in the perinatal period (changes in sleep or appetite). The 10th item specifically
asks about self-harm thoughts. The most commonly used value for a positive screen is
≥13. However, some sources recommend using scores of ≥ 9 for enhanced sensitivity,
arguing that given the potentially detrimental effect of missing cases of perinatal
depression, false positives are preferable to false negatives. Any value > 0 on item 10
(self-harm thoughts) was considered a positive screen and required rapid intervention.
Using a cutoff score of 13, a USPSTF systematic review by O’Connor et al. (2016) found
sensitivity of the English-language ranged from 0.67 (95% CI, 0.18-0.96) to 1.00 (95%
CI, 0.67-1.00). The same systematic review found specificity to be 0.87 across all
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reviewed studies. The EPDS is available for free and published in more than 35
languages at a third to sixth grade reading level.
Items 3, 4, and 5 on the EPDS (known collectively as the EPDS anxiety subscale
or EPDS-3a, Mcbride et al., 2014) inquired about symptoms associated with anxiety
(blaming oneself, feeling anxious or worried, scared or panicky). Some studies validated
the EPDS to screen for perinatal anxiety disorders (Swalm, Brooks, Doherty, Nathan, &
Jacques, 2010), while others concluded more research was needed for validation (Evans,
Spiby, & Morrell, 2015; Matthey, Fisher, & Rowe, 2013).
Postpartum Depression
Screening Scale
The PDSS (Tatano Beck & Gable, 2002) is a 35-item, self-rated, Likert response
scale that assesses seven dimensions including sleeping and eating patterns, anxiety and
insecurity, emotional lability, cognitive impairment, loss of self, guilt and shame, and
thoughts of self-harm. Women are asked to rate their symptoms in the previous two
weeks on a 5-point scale. Scores range from 35-135 with scores of 60 or greater
indicating significant symptoms of depression and 80 or greater indicating a positive
screen for major depression. The PDSS is less widely validated than the EPDS but
literature indicates it performs similarly in terms of sensitivity and specificity (Milgrom
& Gemmill, 2014). The tool is published in English and Spanish at approximately a third
to seventh grade reading level. It is available for purchase for $85 for 25 test forms and a
scoring manual.
Patient Health Questionnaire-9
The PHQ-9 (Kroenke et al., 2001) is a brief, nine-item, self-administered screen.
Questions correlate to DSM-5 (APA, 2013) criteria for a major depressive episode
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including questions about interest in previously enjoyed activities; feeling of depression;
changes in energy, sleep, concentration, and appetite; psychomotor agitation or
retardation; low self-image; and thoughts of death or self-harm. Subjects rate symptom
frequency over the previous two weeks using a Likert scale of 0-3. Total scores of 0-4
suggest minimal or no depression; 5-9 indicate mild depression; 10-14 indicate moderate
depression; 15-19 indicate moderately severe depression; and scores of 20-27 suggest
severe depression. The sensitivity and specificity for major depression are both
calculated at 88% using a PHQ-9 score of ≥10 (Kroenke et al., 2001). The PHQ-9 has
been validated for use screening for prenatal and postpartum depression, though less
widely so than the EPDS. It is freely available and has been translated into dozens of
languages; however, the validity of translations has not been consistently documented.
In a systematic review and evidence report for the USPSTF, O’Connor et al.
(2016) found the EPDS was consistently sensitive to perinatal depression across diverse
populations and languages while concluding “evidence on the accuracy of the PHQ for
pregnant and postpartum women was very limited” (p. 400). Neither the evidence report
nor the Task Force report specifically recommended a single screening tool but
commented there was evidence that screening instruments could help identify women
who needed further evaluation and treatment.
In a 2013 meta-analysis for the Agency for Healthcare Research and Quality,
Myers et al. found a wide range of cutoff values and vague descriptions of testing
protocols in the studies of various screening tools, leading them to conclude “the ideal
characteristics of a screening test for postpartum depression, including sensitivity,
specificity, timing, and frequency, have not been defined” (p. ES-22). They suggested
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that initial screening with a two-item instrument (PHQ-2; Kroenke et al., 2003) followed
by a second, more comprehensive screen, if indicated, might be an appropriate way to
strike a balance of reducing both false positives and false negatives. Finally, they
observed while more studies were needed to elucidate variables, current evidence showed
the availability and accessibility of follow-up care was significantly more important than
the choice of one screening tool over the other.
Mood Disorder Questionnaire
No instruments have been developed specifically to screen for BD in the perinatal
period but the Mood Disorder Questionnaire (Hirschfeld, 2002) has been identified as a
potentially effective tool for such screening. The MDQ is a 15-item, self-report
inventory that is freely available. The screen is divided into three sections: (a) 13 yes-orno questions, (b) co-occurring symptoms, and (c) level of functional impairment
(moderate or serious). As initially validated in an outpatient psychiatric population, the
tool had sensitivity of 0.73 and specificity of 0.9 (Sharma & Xie, 2011). Subsequent
studies showed variation in sensitivity and specificity depending on the population in
which it was used and modification or exclusion of Sections 2 and 3. Frey, Simpson,
Wright, and Steiner (2012) concluded the ideal scoring algorithm during pregnancy and
postpartum used cutoff scores of ≥7 and excluded the supplementary questions, resulting
in sensitivity of 0.88 (95% CI, 0.70–0.98) and specificity of 0.89 (95% CI, 0.82–0.94).
Sharma and Xie (2011) suggested an optimal cut-off score of ≥8 symptoms endorsed
without the supplementary questions with sensitivity of 87.72% (95% CI: 76.32%94.92%) and specificity of 85.29% (95%CI: 74.61%-92.72%).
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Citing the common misdiagnosis of BD as MDD and the potential for worsened
outcomes with inappropriate treatment, Sharma et al. (2018) proposed “changing the
paradigm” (p. 27) of assessment of PPD so a diagnosis of BD must first be excluded
before a diagnosis of MDD can be made. Clark et al. (2015) found that using the MDQ
in conjunction with the EPDS helped differentiate unipolar depression from bipolar
depression in up to 70% of women studied. However, it bears repeating that the MDQ
and EPDS are both screening instruments, not diagnostic tools, and comprehensive
evaluation by a mental health professional is imperative for accurate diagnoses.
Evidence for Screening Intervals
A review of the available literature did not produce any firm evidence to support
specific intervals for screening. In the 2016 recommendation, the USPSTF
acknowledged, “There is little evidence regarding the optimal timing for screening” and
encouraged a “pragmatic approach” (Siu, 2016, p. 382). In the absence of clear evidence,
organizations have adopted recommendations that range from vague (i.e., ACOG’s
[2016] suggestion to screen at least once during the perinatal period) to specific (AAP
[Earls, 2010] recommends screening at the one-, two-, four-, and six-month visits). The
latter was based on recognition that postpartum depression tended to peak at six weeks,
two to three months, and six months after delivery (Earls, 2010). Yawn, Bertram,
Kurland, and Wollan (2015) recommended clinicians consider screening for depression at
6- and 12-months postpartum, noting up to one in three women had elevated depression
screen scores (PHQ-9 score of ≥10) at those intervals. In a study of nearly 9,000 women,
Venkatesh et al. (2016) found women were significantly more likely to complete a
follow-up mental health evaluation if they had a positive depression screen prior to
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delivery compared to after delivery. This might reflect the fact that after birth, women
are busy caring for a newborn and might have less time or energy to tend to their own
health needs, thus highlighting the importance of repeated screening at different points in
the perinatal period.
Evidence for Follow Up/Referral
Throughout the literature, there was consensus that screening alone had little to no
effect on improving outcomes and appropriate follow up, referral to specialists, and
treatment are imperative (Beck & Gable, 2001; Cox et al., 2016; Milgrom & Gemmill,
2014). Although many women might accept screening for depression, they might decline
or not follow through with referral for further psychiatric evaluation and treatment;
additional systems and resources are required to enhance engagement. A variety of
treatment models have been developed to work in conjunction with universal screening to
improve women’s access to treatment, enhance continuity of care, and improve clinical
outcomes. Most of these models are variations of integrated or stepped-care models,
which typically deliver treatment in a step-wise fashion, starting with the least resourceintensive treatment and moving on to more resource-intensive, specialist-provided
treatment as clinically indicated.
Gjerdingen, Katon, and Rich (2008) conducted a systematic review of the
literature in search of the most effective interventions for improving perinatal mental
health. In their findings, they described a stepped care system incorporating the
following:
1.

Screening and diagnosis: screening is completed using a brief, validated tool
followed by clinical interview, if indicated. Patient education is provided
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regarding diagnosis, treatment, and prognosis by the provider or a case
manager.
2.

Initiation of active treatment: psychotherapy and/or pharmacotherapy. This
might be initiated by the primary care (OB) provider or referral to a
specialist.

3.

Specialty consultation in the primary care setting: if illness is complicated or
symptoms persist despite initial treatment, consultation with a psychiatric
specialist would be indicated. Ideally, this would also be completed within
the primary care (OB) office.

4.

Referral to specialty care: should be completed when patients have severe
or persistent mental illness.

Benefits of the stepped-care model include more efficient use of resources,
improved continuity, and improved clinical outcomes. Gjerdingen et al. (2008) noted
women were significantly more likely to engage in treatment when it was integrated than
when they were referred to a distinct office for treatment (71% vs 49%). If at all
possible, they recommended specialty psychiatric care be provided on-site within the
primary care (OB) setting to improve continuity of care, communication, and patient
engagement. Case managers (or care managers) are integral parts of the treatment team
and are able to provide close follow-up and monitoring.
In their 2013 meta-analysis, Myers et al. found completed referral rates were less
than 50% except in studies where screening, diagnosis, and treatment were co-located,
which resulted in “substantially higher” rates of follow up (p. 61). Venkatesh et al.
(2016) also observed improved follow through when a social worker in the OB clinic
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provided in-person or telephone referral to a mental health professional located within the
same OB clinic. They also noted the importance of recording screening scores and
follow up actions in the EMR to prompt providers to continue addressing mental health
needs in future visits.
Summary of the Evidence
A review of the literature showed evidence in support of routine screening for
mood and anxiety disorders during pregnancy and postpartum. Professional and
governmental screening recommendations focused almost exclusively on depression (and
to a smaller extent anxiety) with very little discussion of BD. From a psychiatric and
public health perspective, this might be a dangerous oversight and some experts proposed
a paradigm shift to prioritize screening for bipolar spectrum disorders. Merrill et al.
(2015) noted that initiatives to improve screening for perinatal depression might
“inadvertently lead to misclassification if there was no simultaneous screening for bipolar
disorder” (p. 579). Women with BD who experience symptoms during pregnancy often
present with depressive or mixed symptoms in early pregnancy; without appropriate
diagnosis and mood stabilizing treatment, they are at risk for being treated with
antidepressant monotherapy (Merrill et al., 2015). Use of antidepressants in BD without
appropriate mood stabilization could precipitate hypomania, mania, rapid cycling, and
psychosis, and might increase the risk of suicide or psychosis (Sharma & Xie, 2011).
Sharma, Khan, Corpse, and Sharma (2008) reported that more than half of patients with
depressive episodes in the postpartum period actually had BD, suggesting onset of
depressive symptoms during or after pregnancy might represent a bipolar diathesis.
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At this time, evidence supports use of the EPDS (Mcbride et al., 2014) for routine
screening of perinatal depression but does not necessarily rule out use of other validated
screening tools (PHQ-9, PDSS). In the absence of clear, overwhelming evidence in one
direction or the other, it would be reasonable to take into consideration professional
organizational recommendations, provider preferences, and available resources when
choosing a depression-screening instrument. To date, the MDQ (Hirschfeld, 2002) has
the most evidence to support its use as a screen for BD in pregnant and postpartum
women. Evidence supports use of the EPDS and MDQ together for enhanced detection
of bipolar and major depressive disorders. There is no clear evidence on the optimal
intervals at which screening should be completed but consensus is that screening should
be provided at least once during pregnancy and several times during the first year
postpartum. Beyond simply identifying women experiencing or at risk for PMADs,
routine screening provides an opportunity to discuss risk factors, to educate, and to
normalize women’s experiences.
Throughout the literature echoed the consistent refrain that screening does not
equal diagnosis and screening alone does not improve outcomes. Prompt evaluation by a
qualified mental health professional is essential for accurate diagnosis, treatment
initiation, and follow-up. Careful clinical assessment is imperative to differentiate
unipolar MDD from BD because incorrectly applied treatment could be detrimental. The
stepped care model and co-location of mental health services in the OB setting were
identified as ways to optimize mental health treatment in the perinatal population.
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CHAPTER III
DOCTOR OF NURSING PRACTICE PROJECT
DESIGN AND METHODOLOGY
The purpose of the DNP scholarly project was to develop a guide for screening,
referral, assessment, and treatment of PMADs. This project began by engaging
stakeholders in a productive, ongoing dialogue and involving them in development of a
guide that could be used by primary care providers (OB, certified nurse-midwives, family
practice, pediatrics) to ensure women were being consistently screened, referred, and
treated, and followed appropriately. This guide recommends (a) a screening instrument,
(b) screening intervals, (c) screening and documentation methods, (d) specific clinical
actions to be taken for certain cutoff scores, and (e) a method for transferring care and
assessing follow up once risk or symptoms had been identified. Developing this project
also provided opportunities for education of clinical and non-clinical staff including brief
in-services, question-and-answer sessions, and distribution of printed materials.
Implementation of the guide will occur outside the scope of this scholarly project
as it will require approval and logistical support from Kootenai Health (2018)
administration. Developing a referral destination might take up to a year including time
to recruit, hire, and onboard appropriate staff. Implementation of the final guide will
likely begin with the obstetric practice affiliated with the community hospital (including
obstetricians and certified nurse midwives) and expand over time to include other local
OB providers, primary care, and pediatric practices.
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Stakeholders included providers, nursing, clinical, and administrative staff at
Kootenai Health (including the Family Birthing Center, Kootenai OBGYN, and Kootenai
Outpatient Psychiatry), Heritage Health/Family Support Services, Coeur d’ Alene
Pediatrics, Lakeside Pediatrics, and other local, independent OB providers.
Project Design and Method
This project was a non-experimental field study. The Delphi method was used to
solicit opinions, experiences, suggestions, and concerns of stakeholders. Institutional
Review Board (IRB) approval was granted by the University of Northern Colorado with
the project classified as "exempt" (see Appendix A); each round of Delphi survey
questions was approved separately. The Kootenai Health Nursing Research Coordinator
authorized this author to distribute the survey to several Kootenai Health employees at
their institutional "kh.org" emails (see Appendix B). Invitations to participate in the
study were sent to participants’ personal or work emails depending on their preference.
The introductory email included a brief description of the project and its objectives,
language about informed consent to participate and associated risks/benefits, and a link to
the online platform SurveyMonkey. No risks or ethical considerations were identified
with this field study. No identifiable patient information was exchanged and data were
kept on a password-protected computer in a locked office. Anticipated barriers to
implementation and engagement included individuals’ reluctance to participate in the
survey, primarily concern for survey fatigue or time constraints. To improve
engagement, the surveys were brief, succinct, and easy to complete.
The initial round of the Delphi study used multiple choice and open-ended
questions to query participants’ demographics, comfort/familiarity with various screening
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tools, current clinical practices, and perceived needs (see Appendix C for consent form
and Delphi questions). The second round of the Delphi study presented themes that had
emerged in the first-round responses and asked participants to approve or reject specific
steps in a proposed guideline. Seven individuals participated in the first round of the
Delphi study and six completed the second round. Based on feedback from the initial
survey and supported by evidence in the literature review, the EPDS (Mcbride et al.,
2014) was proposed as a screening instrument and was embedded in the survey for
participants to review (see Appendix D). Participants were asked to approve its use,
along with recommended screening intervals, methods for recording and communicating
scores, actions clinicians should take based on scores, and methods for referral and
follow up.
Results from the second round Delphi survey were adapted into a flowchart (see
Appendix E) intended for use by emergency department and OB clinicians. A
supplementary guideline was developed to provide users with background information,
evidence underlying the recommendations, talking points, and additional resources (see
Appendix F).
Project Evaluation Plan
The stated primary objective of this scholarly project was to develop a guide to
improve the mental health care provided to women in Kootenai County (n.d.) during the
perinatal period. Evaluation of the project, which will focus on assessing how effectively
this guide serves the needs of the community, will occur outside the scope of the DNP
project after the guide had been implemented in the outpatient OB clinic.
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A group of providers, OBs and certified nurse-midwives in the Kootenai Health
(2018) outpatient OB clinic will be asked to utilize the guide. Evaluation will occur after
one to two weeks; however, depending on patient population characteristics (i.e., very
few pregnant or postpartum women being see during those weeks), this timeline will be
extended to collect sufficient data. Evaluation will occur primarily through chart review
(with the assistance of the practice’s clinical coordinator) and face-to-face discussion
with providers. Charts will be selected for review if they belong to a pregnant or
postpartum woman seen by a participating provider within the designated screening times
and will be assessed for use of an appropriate screening tool, documentation of a score,
and documentation of any subsequent actions for treatment or referral. Discussion with
providers will focus largely on their perceptions of the guide and its clinical application,
and solicitation of any feedback they might have to improve its efficacy. Other clinical
and non-clinical staff members will also be interviewed to solicit their feedback about
processes (i.e., a nurse making referrals to mental health offices might have valuable
insights to improve workflow). Finally, providers in the receiving mental health offices
will be interviewed about their experiences receiving patient referrals from the OB
offices and asked to provide feedback to help refine the process.
Timeline
•

March 2019: DNP scholarly project proposal submitted

•

April 2019: Scholarly project proposal defended

•

June 2019: Received University of Northern Colorado Institutional Review
Board (IRB) approval (see Appendix A)
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•

June/July 2019: First round Delphi study conducted (see Appendix C);
results synthesized

•

September 2019: Second round Delphi study conducted (see Appendix D),
results synthesized, guide finalized

•

October 2019: final scholarly project defended

•

Fall 2019––onward: continue development of mental health integration
Resources

Few monetary expenses were incurred for development of this scholarly
project. Paper, printer cartridges, and additional office supplies were the primary
expenses and were purchased by this author. The online platform SurveyMonkey was
used to disseminate the Delphi study and the author paid for the subscription.
Participants graciously donated their time to respond to the study and participate in
follow-up discussions.
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CHAPTER IV
DATA ANALYSIS AND RESULTS
The Delphi method was used to solicit the opinions, experiences, suggestions, and
concerns of stakeholders. Participants included OB providers, mental health providers,
therapists, and clinical social workers. Most of the participants were employees of
Kootenai Health and Heritage Health. One was a certified nurse midwife (CNM) from a
local OB practice and one was an employee of Bonner General Hospital, a critical access
hospital located approximately 45 miles north of Kootenai Health. Kootenai Health
administrative staff members were invited to participate but did not. Stakeholders were
sent an email link to the survey using the online platform SurveyMonkey. Information
about privacy practices and informed consent to participate were embedded in the
invitation email as well as the introduction page on the survey website. The first survey
was available online from June 22 through July 22, 2019. Participation was lower and
slower than anticipated, possibly due to the summer vacation season. The surveys
included multiple choice and open-ended questions. The first and second round Delphi
questions are attached in Appendices C and D, respectively. Responses were kept
confidential.
Delphi Round One Questions
The first Delphi study solicited demographic information and asked broad
questions to survey the current/local healthcare landscape and assess perceived need.
Seven individuals participated in the first round. The first question asked: “What is your

71
role?” Table 3 presents the responses participants gave regarding their role within the
organization.

Table 3
Role of Participants
Role

N

%

Administrative

0

0

OB provider: CNM

1

14.29

Mental Health Provider: Psychiatrist, NP

3

42.86

Social Worker

2

28.57

Therapist

1

14.29

RN

0

0

Other

0

0

Note. One participant, a CNM, inadvertently identified herself as a mental health
provider. If corrected, two participants were OB providers (28.57%) and two were mental
health providers (28.57%).
The second question asked: “Do you encounter PMADs in your professional role?
–either directly, providing patient care, or indirectly, in developing systems/programs.”
Six respondents (85.71%) answered “Yes” and one (14.29%) participant responded “No.”
Estimated frequencies given by the participants were “at least twice a week,”
“approximately 10 patients annually,” “several patients monthly, between 3-5,” “1-2x
month,” and “I would say at least 60% of our pregnant patients have some sort of
PMAD.”
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The third question asked: “Are you (or your organization) currently using any sort
of guideline/protocol in clinical practice with regards to PMADs?” The majority of
respondents (4; 57.14%) indicated their organization did not consistently use a clinical
guideline or protocol for screening and referral of PMADs. Among respondents whose
offices/organizations used a screening protocol, there was variability and little detail was
provided. One respondent (OB provider) described “q trimester screening, and have a
protocol for follow up when patients screen positive. Depending on severity, follow up
may include additional visits with CNMs, social work, psychiatry, and or/behavioral
health.” A mental health provider responded:
EPDS is provided in the OBGYN clinic at each post-partum visit, prior to referral
to this office. Protocols for referral and treatment to psychiatry are being
developed currently. Primary issue at this time is that 50% of referrals to
outpatient psychiatry from OBGYN do not show up for appointment or will not
schedule. Are working towards some type of imbedded role within OB clinic.
Also, desperately need social work/case management role to manage this
population in order to improve access and adherence to treatment.”
A social worker wrote:
I am unsure of the protocol but as a [social worker] on [labor and
delivery/postpartum] (6 years ago) we were using screening tools. On psychiatric,
I am unaware that the [emergency department social work] triage staff or the
therapists [inpatient] use any.
The fourth question asked: “Are you (or your organization) currently using a
formal instrument to screen for PMADs?” Fewer than half the respondents (3; 42.86%)
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indicated they were using a formal instrument to screen for PMADs. One was unsure
which instrument was being used; one was using the EPDS, and one was using the PHQ9 and noted: “I dislike that it is not pregnancy specific, but I like that you can follow it
throughout the patient’s care even after the perinatal period.”
The fifth question asked: “What would you like to see in a guideline for screening
and treatment of PMADs? (select as many as apply).” This question—which asked
respondents to choose what they would like to see in a guideline for screening/treatment
of PMADs—should have been published as “select all that apply.” However, due to the
author’s error, the survey only allowed participants to select one answer. Two
respondents (28.57%) identified “recommended screening tools,” another two (28.57%)
chose “recommended actions for positive screens,” two (28.57%) chose “referral
destinations for patient follow up,” and one (14.29%) selected “suggested talking points
to discuss with patients.” Two commented that the question should have been “select all”
and one requested “a more streamlined method for getting patients scheduled/ or invested
in follow-up […] more community therapists able to work with this population [and] case
management role would be very helpful.”
The sixth question asked: “What is your current referral process for women who
need more specialized mental health treatment?” Free-text responses included: “[social
work] staff calling around to see who can take new patients,” “referral to our clinics
mental health department,” “referrals are sent from the OB clinic to the Outpatient
Psychiatry clinic. Phone consult also available between providers.” Other processes
mentioned were “referral to generalized counseling services” and “referral to local
providers, who are overbooked.” One respondent, an OB provider in a metropolitan area,

74
wrote: “We refer within our system (Kaiser) if resources are available, or to our local
lactation support center that includes a specialized perinatal mood disorder division.”
The seventh question asked: “In your professional experience, what proportion of
women who need specialized mental health treatment receive adequate
treatment/services?” Figure 1 provides participants’ responses regarding proportions of
women who needed specialized mental health treatment and actually received it.

Frequency
3

2

1

0
0-9

10-19

20-29

30-39

40-49

50-59

60-69

70-79

80-89

90-100

Figure 1. Proportion of women who needed and received specialized mental health
treatment.
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The eighth question asked: “From your perspective, what are barriers to the
screening/assessment/referral/treatment of PMADs in our community?” Seven
participants identified a generalized lack of mental health resources (therapists, providers,
case managers) as well as a lack of specialty resources for this vulnerable population.
One mental health provider noted: “Stigma seems to prevent women from coming to the
outpatient psychiatry clinic, and our OB’s have stated that they feel the engagement rate
would increase with an imbedded provider.” One social worker identified a “lack of
inclusion in standards or care and metrics” as a barrier.
The ninth question asked: “From your perspective, what would most improve the
care of PMADs in our community?” Participants provided the following responses:
•

“Available psychiatric providers and skilled therapeutic clinicians.”

•

“Resources that include a team of counselors, NP and support groups for
just PMAD.”

•

“Medical and mental health provider education; access to recommended
assessment/screeners; referral resources.”

•

“An actual program with protocols and support from the organization.”

•

“Encouraging providers to have conversations and ask about symptoms,
educating patients on what to look for and normalizing how they feel.”

•

“Improved education of providers, improved screening and improved
availability of resources for those in perinatal period. Lytle Center in Seattle
is an example of a good start.”

•

“In-house specialized mental health providers, dedicated perinatal social
worker (we used to have one and now only have generalists that serve the
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entire campus and don't have specialized knowledge of perinatal-related
resources.”
The final question asked: “Do you have any other questions, suggestions, or
concerns?” The only additional suggestion (from an OB provider) was to provide a list of
medications that might be indicated by various symptoms. She noted some providers
“sometimes feels like [we] just use what [we are] most comfortable prescribing.”
Analysis of the open-ended questions revealed consistent themes including a
general consensus that there was a global lack of resources to identify and support
women at risk for PMADs. Respondents indicated institutional changes are necessary to
improve mental health care for this population. Participants supported standardized use
of validated screening tools and data analytics, enhanced systems for referral, and
development of dedicated perinatal mental health services. Based on responses from the
first survey and using published algorithms as a guide (Puryear, 2018; UNC, 2016), a
second round of Delphi questions was developed asking participants to approve or reject
individual steps in a proposed guideline. The survey comprised 16 discrete steps and the
final item was a free-text field asking for questions, comments, and suggestions. The
second round of Delphi questions was submitted to the University of Northern
Colorado’s IRB on August 6, 2019, and was approved on September 6, 2019. The survey
was sent to the seven participants who had completed the first round and again included
information about informed consent, privacy practices, and a link to the online platform
SurveyMonkey (see Appendix D). The survey was available from September 10, 2019,
until September 25, 2019. Six individuals completed the second round.
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Delphi Round Two Questions
Delphi round two consisted of 16 discrete questions pertaining to the appropriate
screening instrument (question 1), appropriate screening intervals (questions 2 and 3),
screening method and recording results in the medical record (question 4), whether the
emergency department’s clinician judgment should be used to determine whether the
patient met criteria for admission and if admission was the most appropriate intervention
(questions 5 through 9), methods of transferring care (questions 10 through 13), and the
ideal integrated mental health model (questions 15 through 16). The final item (question
17) was a free-text field asking for questions, comments, and suggestions. All six
participants indicated approval of all 16 discrete questions except for one non-response to
question 11. One participant made the following comment in the free-text field: “This is
an invaluable service to the families in this community. Thank you.”
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CHAPTER V
DISCUSSION
Summary
This project began—as many do—with personal interest in a topic. The author
had been interested in women’s mental health issues for several years and during her first
pregnancy became more acutely aware of the lack of local resources for PMADs. This
DNP scholarly project emerged as an ideal vehicle to transform a personal interest area
into an actionable, evidence-based intervention. Over the course of her DNP studies, this
author’s knowledge of healthcare systems, population-based healthcare, leadership
strategy, and policy development expanded dramatically and she became increasing
passionate about directing her energy and skills into the project.
As the project took shape, this author immersed herself in the subject matter. She
progressed from casually reading articles and watching webinars to undertaking a
comprehensive review of the literature and an appraisal of the evidence. The author
developed a deeper understanding of the background and significance of PMADs
including their risk factors, prevalence, controversies, and impacts. She identified
recommended best practices and analyzed the evidence to support them. She
confirmed—first through informal conversations and later through a formal, IRBapproved Delphi study—that PMADs were under-detected and undertreated in her local
healthcare system and that there was an urgent need in the community for an improved
system of care.
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This author used a Delphi study to build consensus across an expert panel of
stakeholders including OB providers, mental health providers, and social workers. She
synthesized evidence from the literature review to propose a guideline and model of care
to improve the detection, treatment, and follow up of PMADs in the community. The
guide met each objective outlined in Chapter III including identifying (a) an appropriate
screening instrument, (b) appropriate screening intervals, (c) screening methods and
processes for recording results in the medical record, (d) specific actions the clinician
should take based on pre-established cutoff scores, and (e) a method for transferring care
and assessing follow up once risks or symptoms had been identified. Finally, an
integrated mental health model was proposed, wherein a social worker and/or PMHNP
would be embedded in the outpatient OB clinic to improve access and continuity of care.
The expert panel unanimously approved each step in the guide and affirmed the need for
ongoing advocacy, investment of resources, and process refinement.
Limitations
This project was completed largely within the KH organization, initially with the
hope the resulting guideline would be implemented into clinical practice. However, the
academic and organizational timelines were asynchronous and as of the time of the
scholarly project defense, the actual implementation remained theoretical and could not
be evaluated in situ. As of late 2019, Kootenai Health leadership was considering
strategic development goals for 2020 and exploring funding and staffing needs. The
author and stakeholders remain optimistic the New Year will bring new opportunities for
growth and improvement.
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No single formula in the literature delineated an “ideal” way to approach PMADs
from a population perspective. There are wide variations in current clinical practice
across communities, states, and the nation. There are multiple screening instruments,
possible screening intervals and methods, and various systems for follow up, each of
which might be influenced by provider preference, organizational culture, and available
resources. This guide was designed specifically for use by KH ED staff and OB
providers who deliver just over half the babies in Kootenai County annually (53%;
personal communication with Megan Smith, OB nurse manager, July 2018).
Obstetrics providers from several other local practices had expressed interest in
the subject and would benefit from sharing the guide with minor adaptations in the
referral process (they would likely not have the patient volume to warrant embedding a
mental health provider in their offices but would like to refer patients to the case manager
or PMHNP in the Kootenai OBGYN office). That embedded mental health provider
could also become a potential referral destination for local pediatrics offices, some of
which currently screen postpartum mothers but struggle to link women with positive
screens to appropriate treatment (personal communication with Haley Buhl, pediatric
nurse practitioner, November 2018). Establishing an expedited referral process to mental
health clinicians at Heritage Health and Family Support Services would help expand
available resources and streamline care, especially in the future if demand within the OB
office exceeds available clinical time or if women need ongoing mental health services
after the first year postpartum.
This project did not address specific treatment recommendations (medications or
therapy modalities, for example) and the recommended screening instrument was
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indicated primarily for depression and anxiety. Screening for mania, hypomania, and
psychosis was not directly addressed in the guide; further refinement based on feedback
and experience will be necessary once the guide is implemented.
Recommendations
Throughout the literature review process and the Delphi study, it was evident
inadequate mental health services were available across the nation and the author’s
community. In recent years, improved advocacy has led to better legislation and
increased funding for PMAD-related issues but there is still much work to be done. The
demand for funding, high-quality research, education, and services should continue to
intensify. Kootenai Health and other local organizations should pursue grant funding and
improved insurance reimbursement and should direct their strategic planning to develop a
robust perinatal mental health program.
Once funding has been approved, a PMHNP and/or case manager should be
embedded within the OB clinic and the guideline should be implemented promptly.
Evaluation should be ongoing to ensure that processes are as smooth and effective as
possible. Staff across practice setting should be offered continuing education to help
them improve their knowledge bases and comfort levels in relation to PMADs. The
author and other stakeholders would need to stay up-to-date with emerging evidence
through ongoing education, literature review, and peer consultation.
Because postpartum depression tends to peak at six weeks, two to three months,
and six months after delivery (Earls, 2010), additional screening should be considered
beyond the six-week postpartum follow-up visit. In current practice, the six-week
follow-up visit is often the last contact a woman would have with her OB provider until
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her next annual exam or next pregnancy. The American College of Obstetricians and
Gynecologists (2018) recommended a shift in the delivery of postpartum care,
encouraging more frequent follow up and increased attention to emotional wellbeing. As
local OB providers adapt their practices, screening intervals could be modified to reflect
community needs. Coordination with local pediatric providers will be vital as they tend
to have frequent contact with parents during the child’s first year of life.
Additional areas for expansion include community education sessions, support
groups, peer support programs, and patient education sessions that could be offered preconception, during pregnancy, on the OB unit, and at postpartum follow up. On a larger
scale, Idaho should begin to participate in the Pregnancy Risk Assessment Monitoring
System (PRAMS), a program developed in 1987 as a collaboration between the Centers
for Disease Control and Prevention (CDC; 2019) and state departments of health to
reduce perinatal mortality. A population-based surveillance system, PRAMS identifies
groups of women and babies at risk and monitors health status, identifies emerging
issues, and evaluates policies focused on improving infant health. Data are collected on
prevalence of depression before, during, and after pregnancy but, unfortunately, Idaho is
one of only three states that does not participate in PRAMS (CDC, 2019). Joining
PRAMS would help leaders improve health policy and better allocate resources for
women and infants in the state.
Developing a Clinical Practice Guideline
While the guide developed through this scholarly project was not truly a “clinical
practice guideline,” which would have had a significantly broader and deeper scope,
some of the principles and practices of clinical practice guideline development were
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employed in this project. This approach helped this author structure her project to
effectively translate evidence into clinical practice.
The Institute of Medicine (Rosenfeld & Shiffman, 2009) identified seven criteria
for identifying priority in guideline development including disease burden, controversy,
cost, new evidence, potential impact, public or provider interest, and variation in care.
Most of these criteria pertained to the screening and treatment of PMADs.
•

Disease burden. Perinatal mood and anxiety disorders are prevalent and
serious; they are one of the most common complications of
pregnancy/childbirth and result in significant impairment, mortality, and
morbidity (Earls, 2010; O’Hara & Wisner, 2014). Estimates of prevalence
in Kootenai County were consistent with national data; yet, the region has
lower-than-average access to specialized mental health treatment, resulting
in under-detection and under-treatment (Mental Health America, 2018).

•

Cost. The economic impacts of PMADs are significant and include direct
healthcare costs as well as indirect costs from lost wages, diminished
productivity, and increased healthcare utilization related to comorbid
conditions (Greenberg et al., 2015; Kessler, 2012).

•

New evidence. Emerging evidence indicates standardized screening for
PMADs could improve outcomes when paired with appropriate systems for
follow up and management (Beck & Gable, 2001; Cox et al., 2016; Milgrom
& Gemmill, 2014). In the past decade, integrated and stepped-care models
have been shown to optimize utilization of valuable mental health resources
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while improving the quality of care available to vulnerable populations
(Gjerdingen et al., 2008)
•

Potential impact. Improving the detection and treatment of PMADs has the
potential to improve the health of not just the mother but also her child(ren),
partner, extended family, and community. Early intervention might help
minimize or avoid potentially devastating outcomes (Hoffman et al., 2017;
Seymour et al., 2014). A standardized guideline might help improve the
efficiency and quality of services available to a vulnerable population.

•

Public or provider interest. Recent years have seen a groundswell of
awareness of PMADs. Providers and consumers alike recognize the need
for improved systems for healthcare delivery. Local stakeholders in
Kootenai County have requested evidence-based recommendations to guide
patient care and systems-level decision making.

•

Variations in care. Significant differences exist in the detection and
management of PMADs across practice settings (Evans et al., 2015).
Professional organizations offer vague recommendations but do not clearly
define clinical pathways or interventions. A well-designed guide would
help reduce variations in care and improve the overall quality of care.

Once an appropriate topic has been identified, use of a standardized method
facilitates guideline development. Shekelle, Woolf, Eccles, and Grimshaw (1999)
identified five steps integral to the development of evidence-based guidelines including
(a) identifying and refining the subject area, (b) convening and running guideline
development groups, (c) assessing evidence identified by systematic literature review, (d)

85
translating evidence into recommendations, and (e) subjecting the guideline to external
review.
In this scholarly project, the author identified and refined the subject area (step 1)
during the early stages of the endeavor, roughly corresponding to Phase I: Preparation of
the Stetler (2001) theoretical framework. As noted in Chapter II, this stage involved
identifying the problem, defining the purpose and outcomes of the project, affirming
priorities, and beginning an initial review of sources of information.
This project did not utilize guideline development groups (step 2) but did engage
stakeholders in the development of the guide through ongoing discussion and through the
Delphi studies. The third step, assessing evidence identified by systematic literature
review, corresponded to Stetler’s (2001) Phase II: Validation. A comprehensive review
of the relevant literature was undertaken at the beginning of the scholarly project and
continued during its development. The fourth step, translating evidence into
recommendations, corresponded to Stetler’s Phases III: Comparative Evaluation &
Decision-Making and IV: Translation/Application. This was accomplished through use
of the Delphi study to assess stakeholders’ current practices, perceived needs, barriers,
and available resources. High-quality evidence identified in the literature review was
translated into a clinically relevant guide that fit the needs of the target population.
The final step, subjecting the guideline to external review, was partially
accomplished in Round 2 of the Delphi study, wherein participants were asked to approve
or reject 16 steps of the proposed guideline. Further external review will be completed
if/when the guide is implemented in the organization. This would correspond to Stetler’s
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(2001) Phase V: Evaluation, and would include discussion with stakeholders, chart audit,
and case review.
Reflections on Doctor of Nursing Practice Education
The AACN (2006) described the Doctor of Nursing Practice degree as the
“practice-focused” terminal degree of nursing education (p. 3). Rather than generating
knowledge or developing theories as their Ph.D. colleagues might, the skill of the DNPprepared nurse lies in his/her ability to translate evidence into clinical practice, to
synthesize data, and to apply it constructively and collaboratively to improve systems and
practices with the goal of improving the health of individuals and populations.
In their 2006 document entitled The Essentials of Doctoral Education for
Advanced Nursing Practice, the AACN detailed eight core competencies of DNP
education and practice. These, in conjunction with specialized clinical content
established by national specialty nursing organizations, form the two major components
of DNP curricula. The congruence of the author’s DNP education at the University of
Northern Colorado (UNC) and her scholarly project with those essential components are
discussed below. The scholarly project’s success was evaluated using the acronym EC as
PIE (enhance, culmination, partnership, implement, and evaluation), which has been
adopted as a standard rubric for measuring the quality of DNP scholarly projects.
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Essentials of Doctoral Education for
Advanced Nursing Practice
Essential I: Scientific Underpinnings
for Practice
The DNP curriculum at UNC involved rigorous studies across the natural and
social sciences. Coursework included statistics, epidemiology, population health
management, healthcare finance, leadership, health policy, and nursing theory. The
scholarly project incorporated evidence and knowledge from multiple sources and
specialty areas. By undertaking a comprehensive review of literature, the author
developed a deeper understanding of the etiology and treatment of PMADs as well as
social factors that influence the delivery of health care.
Essential II: Organizational and
Systems Leadership for Quality
Improvement and Systems
Thinking
Through her leadership courses and practicum, the author had the opportunity to
learn about local healthcare systems and effective leadership strategies. This knowledge
prepared her to more effectively propose changes. She also formed professional
relationships during the practicum that helped facilitate discussions during the project
development phase.
Developing the scholarly project required the author to step outside her familiar
role as a direct provider of healthcare into a position where her focus expanded to the
entire community. This shift was challenging—and at times uncomfortable—but
provided invaluable learning experiences. A shortage of qualified perinatal mental health
providers exists and developing more efficient systems within existing organizations

88
would be the most efficient and sustainable way to improve the quality of care and
expand access.
Essential III: Clinical Scholarship and
Analytical Methods for EvidenceBased Practice
Translation of evidence into action is the foundation of advanced nursing practice.
Courses in epidemiology, research methods, and statistics prepared the author to assess
and synthesize evidence and to apply it to clinical practice. The author used critical
thinking, a comprehensive literature review, and data analysis to assess needs, identify
best practices, and develop a guide to improve patient-centered care. She proposed
methods for ongoing collection of evidence to further refine interventions and improve
outcomes.
Essential IV: Information Systems/Technology
and Patient Care Technology for the
Improvement and Transformation
of Health Care
The author displayed proficiency using a web-based survey platform to collect
and synthesize data. She used online databases to search for relevant literature. The
author expanded her familiarity with Kootenai Health’s electronic health record (EHR)
and identified ways in which data could be more accurately collected and managed.
Essential V: Health Care Policy for
Advocacy in Health Care
The delivery of healthcare is influenced by policies on organizational, local, state,
and national levels and DNP-prepared nurses are well qualified to effect change on each
of those levels. The UNC healthcare policy courses provided the author with a solid
understanding of how policies are developed and prepared her to advocate for change.
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This scholarly project sought to influence policy on the organizational level, specifically
by advocating for expanded allocation of resources to benefit a vulnerable population.
The author also mobilized local stakeholders to advocate on behalf of their clients for
additional mental health services.
Essential VI: Interprofessional Collaboration
for Improving Patient and Population
Health Outcomes
Perinatal mental health sits at the confluence of mental health, women’s health,
primary care, and pediatrics. This scholarly project required collaboration across
different healthcare specialties and settings—from outpatient OB to labor and delivery,
from the emergency department to psychiatry. The author participated in collaborative
meetings with OB, mental health, primary care, and pediatric providers, as well as
Kootenai Health leadership, and helped facilitate communication across specialty areas.
Apart from the scholarly project, she was able to provide an educational in-service to
community midwives and OB providers and phone consultation for OB and mental health
providers. She has been working with the labor and delivery unit to develop an
educational video that all mothers will watch before being discharged from the hospital.
Essential VII: Clinical Prevention and
Population Health for Improving the
Nation’s Health
The primary purpose of this scholarly project was to develop a comprehensive
guide to improve mental health care provided to women in Kootenai County during the
perinatal period. The DNP-prepared nurse is ideally positioned to enact population-level
interventions, which is critical in the field of mental health given the global shortage of
specialists, and this need is even more pronounced in the specialty area of PMADs. The
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University of Northern Colorado’s DNP curriculum prepared the author to evaluate
current care delivery models and synthesize findings from current literature and the local
community into a framework that would improve the quality of care for an underserved,
vulnerable population.
Essential VIII: Advanced Nursing
Practice
The University of Northern Colorado’s DNP curriculum provided the author with
new educational (and eventually professional) opportunities. After completing advanced
practicum clinical hours at KH in the first year of the program, she was invited to join the
organization full-time. Her clinical skills sharpened with immersion in new healthcare
settings and eventually the DNP program challenged the author to expand her focus from
providing direct patient care to developing systems-based interventions. She has
immersed herself in a specialty area and has had the privilege of being a preceptor to
nurse practitioner students. She has also had the opportunity to provide PMAD education
to colleagues across the community. Through the course of study, the author has
developed the clinical judgment, analytical skills, and ability to work collaboratively,
which are the hallmarks of advanced practice nursing.
Enhance, Culmination, Partnership,
Implement, and Evaluation
Waldrop, Caruso, Fuchs, and Hypes (2014) proposed “EC as PIE” as a method of
evaluating “whether a DNP final project meets the outcomes of the AACN’s Essentials of
Doctoral Education in Advanced Nursing Practice” (p. 300). The authors noted that with
the proliferation of DNP programs since 2006—and wide variations in curricula and
academic rigor—it is imperative to ensure the DNP graduate has truly met the outcomes
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established by the AACN (2006). The acronym EC as PIE represents five criteria that
must be met by a DNP scholarly project.
•

E = Enhance health outcomes, practice outcomes, or health policy. The
author evaluated current practices and found that screening, referral,
treatment, and follow up of PMADs in her community were inconsistent,
resources were inefficiently distributed, and patient outcomes were
adversely impacted. The scholarly project proposed comprehensive changes
to improve the quality and consistency of care to improve outcomes across
practice settings.

•

C = Reflect a culmination of practice inquiry. During development of this
scholarly project, the author immersed herself in the subject matter from
clinical and systems perspectives. She undertook advanced training and
became certified as a perinatal mental health provider through Postpartum
Support International. She gained a deep and broad understanding of
historical issues, best practices, scientific developments, and legislative
efforts in the field and used this knowledge to effect change.

•

P = Require engagement in partnerships. The author collaborated with
stakeholders across the community from diverse backgrounds including
direct healthcare providers, healthcare administrators, and consumers. She
found many colleagues had been personally impacted by PMADs and were
fiercely supportive of the project.

•

I = Implement/apply/translate evidence into practice. The author first
gathered evidence through the literature review process and then synthesized
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it into a recommended plan of action that fit the needs of the local
community.
•

E = Require evaluation of health care, practice, or policy outcomes. The
initial stages of this scholarly project involved evaluating the current
processes for screening, referral, treatment, and follow up of PMADs. The
author has proposed a method of ongoing evaluation once the proposed
guide/practice model is implemented.
Conclusion

Perinatal mood and anxiety disorders are serious, prevalent, and treatable but
under-detection, exacerbated by inadequate/inefficient use of resources, has resulted in
many women not receiving appropriate treatment. Improved systems for screening,
detection, referral, treatment, and follow up of women with or at risk for PMADs are
imperative to protect the health of women, their children, families, and communities.
This scholarly project examined current literature to identify best-practices and proposed
a model of care to improve health outcomes across a community. This author built
support for her project and formed a coalition of mental health and OB professionals who
continue to work collaboratively to enhance the quality of care in Kootenai County.
Ongoing work is needed to implement and evaluate the guide and to expand services to
further match the community’s needs.
The DNP-prepared nurse is able to adapt to the ever-changing healthcare
landscape and is uniquely qualified to effect change across varied and complex settings.
This project embodied the integration of scholarly interest, clinical expertise, and
advanced nursing practice. As she transitions from student to graduate, this author will
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continue to hone her skills, expand her knowledge base, and collaborate across the
spectrum of care to improve the mental health of women, children, and families in her
community.
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CONSENT FORM FOR HUMAN PARTICIPATION IN RESEARCH
Project title: Perinatal Mental Health:
Improving the Quality and Consistency of Healthcare Delivery in Kootenai County
Student Researcher: Leanne Elisha, PMHNP (DNP Student)
Research Advisor: Kathleen N. Dunemn, PhD, APRN, CNM, School of Nursing
Co-Advisor: [name, credentials]
Committee Member: [name, credentials]
Expert Consensus via a Delphi Study
Dear Participant, I am completing a DNP Scholarly Project to improve perinatal mental
health care in Kootenai County.
The primary goal of this project is to develop a guide to improve identification, referral,
treatment, and follow-up perinatal mood and anxiety disorders (PMADs). This guide will
identify:
1. An appropriate screening instrument
2. Appropriate screening intervals
3. Screening method and process for recording results in the medical record
4. Specific actions the clinician should take based on pre-established cutoff scores
5. A method for transferring care and assessing follow up once risk or symptoms
have been identified.
6. A proposed model for integrating mental health into the primary care/OB setting.
The Delphi Method will be used to solicit stakeholder opinion, interest, and feedback and
to build consensus. It is anticipated that two rounds will be necessary for completion of
this project. The first round of questions will focus on general awareness of PMADs,
screening recommendations, and current practice, as well as areas of perceived need.
Subsequent rounds will focus on building consensus and developing a practical guide to
improve clinical practice.
All Delphi surveys will be sent and returned electronically with a private e-mail account
only accessible by the DNP student. It is estimated that each participant will spend
approximately 10-15 minutes in completion of survey questions within each round of the
Delphi process.
Delphi survey responses will be kept confidential. Participation is voluntary. If you
know any providers or stakeholders that may be interested in participating in these
surveys, please forward this email to them. If you begin to participate, you may decide to
stop or withdraw at any time. If you have any questions, please contact one of the
undersigned. Having read the above document and having had an opportunity to ask any
questions, please access the link [insert survey link] to complete the survey.
If you complete the survey, it will be assumed that you have communicated consent for
your participation. You may keep this form for future reference. If you have any concerns
about your selection or treatment as a research participant, please contact Sherry May,
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IRB Administrator, office of Sponsored Programs, Kepner, Hall, University if Northern
Colorado, Greeley, Co 80639. Phone 970-351-1910.
This informed consent will be e-mailed and accompany each round of the Delphi study.
Student Researcher: Leanne Elisha, PMHNP, DNP-S.email:
elis5570@bears.unco.eduPhone:
Research Advisor: Kathleen N. Dunemn, PhD, APRN, CNM. email:
Kathleen.Dunemn@unco.eduPhone: (970) 351-3081/ (303) 649-5581
Co-Research Advisor: [name, credentials], [email], [phone]
Committee Member: [name, credentials], [email], [phone]
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Round One Delphi Questions:
Thank you for your participation in this survey. The objective of this project is to
improve the detection, referral, and treatment of perinatal mental health issues in our
community. The questions below pertain to perinatal mental health issues, including
pre/postpartum depression, anxiety, mania, and psychosis, collectively referred to as
perinatal mood and anxiety disorders (PMADs). Please answer as fully as possible and
feel free to elaborate or qualify your responses. All responses will be kept confidential.
If you have any specific questions regarding the survey or the project, please email
Leanne Elisha at lelisha@kh.org.
1) What is your role?
o Administrative: _______
o OB provider: (CNM, OB)
o Mental health provider: (psychiatrist, NP)
o Social worker
o Therapist: (LPC, MSW, LCSW, etc)
o RN
o Other
2) Do you encounter PMADs in your professional role? (either directly, providing
patient care, or indirectly, in developing systems/programs)
o Yes: ___ if so, please estimate the frequency
o No
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3) Are you (or your organization) currently using any sort of guideline/protocol in
clinical practice?
o Yes: If yes, please describe. What do you like/dislike about the
guideline you currently use? _____________________
o No
4) Are you (or your organization) currently using a formal tool to screen for PMADs?
o Yes: If yes, which tool? What led you to choose this tool? What do
you like/dislike about it? ___________________________
o No
5) What would you like to see in a guide?
o Recommended screening tools
o Recommended screening intervals
o Suggested talking points to discuss with patients
o Recommended actions for positive screens
o Referral sources for patient follow up
o Local contacts for professional consultation (peer-to-peer consult)
o Other: ____________________________
6) From your perspective, what are barriers to the
screening/assessment/referral/treatment of PMADs in our community:
________________________________________________________________
7) From your perspective, what would most improve the care of PMADs in our
community?
_____________________________________________________________________
Do you have any other questions, suggestions, or concerns?
________________________
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CONSENT FORM FOR HUMAN PARTICIPATION IN RESEARCH
UNIVERSITY OF NORTHERN COLORADO
Project title: Perinatal Mental Health:
Improving the Quality and Consistency of Healthcare Delivery in Kootenai County
Student Researcher: Leanne Elisha, MS, PMHNP, DNP-S
Research Advisor: Kathleen N. Dunemn, PhD, APRN, CNM, School of Nursing
Committee Member: Faye Hummel, RN, PhD, CTN-A, ANEF, School of Nursing
Committee Member: Carolyn Bottone-Post, DNP, RN, CNM, School of Nursing
Contact Information:
Student Researcher: Leanne Elisha, MS, PMHNP, DNP-S
Email: elis5570@bears.unco.edu
Research Advisor: Kathleen Dunemn, PhD, APRN, CNM
Email: Kathleen.Dunemn@unco.edu
Phone: (970) 351-3081/ (303) 649-5581
Expert Consensus via a Delphi Study: Round 2 Delphi Questions
Project Purpose: Dear Participant, you are invited to participate in Round 2 of my DNP
Scholarly Project to improve perinatal mental health care in Kootenai County.
The primary goal of this project is to develop a guideline to improve identification,
referral, treatment, and follow-up perinatal mood and anxiety disorders (PMADs). The
final guideline will identify:
1. An appropriate screening instrument
2. Appropriate screening intervals
3. Screening method and process for recording results in the medical record
4. Specific actions the clinician should take based on pre-established cutoff scores
5. A method for transferring care and assessing follow up once risk or symptoms
have been identified.
6. A proposed model for integrating mental health into the primary care/OB setting.
Project Description: The Delphi Method will be used to solicit stakeholder opinion,
interest, and feedback and to build consensus. It is anticipated that two rounds will be
necessary for completion of this project. The first round of questions focused on general
awareness of PMADs, screening recommendations, and current practice, as well as areas
of perceived need. This round focuses on building consensus and developing a practical
guideline to improve clinical practice.
In the first round of the Delphi study you were asked to respond to ten (10) questions
related to perinatal mental health issues. This round contains sixteen (16) questions.
Each asks you to approve or reject a proposed step in the guideline. Comments are
invited on all questions but not required. It is estimated that it will take 10-15 minutes to
complete these questions. No compensation will be offered. There will be no form of
deception used.
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Risks and Benefits of Participation: The risks inherent in this study are no greater than
those normally encountered during regular daily activities. The potential benefit of this
study is enhanced provider/administrator engagement in the development of improved
systems for providing care to an underserved population.
Confidentiality Procedures: Delphi survey responses will be kept confidential. All
Delphi surveys will be sent and returned electronically with a private e-mail account only
accessible by the DNP student. Data will be stored on a password-protected computer in
a locked office. Responses to questions will be kept confidential, but because the panel
of experts has been hand-selected by the student researcher and the project may include
face-to-face discussion and focus groups, anonymity is neither inferred nor assured.
Participation is voluntary. If you begin to participate, you may decide to stop or
withdraw at any time. If you have any questions, please contact one of the undersigned.
Having read the above document and having had an opportunity to ask any questions,
please access the link [insert survey link] to complete the survey.
If you complete the survey, it will be assumed that you have communicated consent for
your participation. You may keep this form for future reference. If you have any concerns
about your selection or treatment as a research participant, please contact Sherry May,
IRB Administrator, office of Sponsored Programs, Kepner, Hall, University if Northern
Colorado, Greeley, Co 80639. Phone: (970) 351-1910.
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Round 2 Delphi Questions
Thank you for your participation in the first round and for your feedback.
Your responses are consistent with themes in the literature. Identified themes include:
there are insufficient resources available to detect, much less treat, perinatal mood and
anxiety disorders (PMADs). Specialized clinicians and referral destinations must be
identified/developed. Stigma around mental health issues interferes with treatment
engagement and lowers participation. Institutional support is required to build a more
coherent, accessible system to care for these patients.
Based on your responses, I have proposed a model of care. Please take the time to review
the proposal below and approve or reject each item. Feedback is greatly appreciated.
This is currently a theoretical project; actual implementation will require administrative
investment and support.
Regarding the assessment and care of PMADs in the Kootenai Health system, please
approve or reject the following:
Appropriate screening instrument:
1. Kootenai Health OB providers will begin screening pregnant and postpartum
women for PMADs using the Edinburgh Postnatal Depression Scale (EPDS).
This tool is attached for easy reference.
o Rationale:
▪ EPDS is a widely used, freely available tool that is validated for
assessment of postpartum and antennal depression (McBride et al.,
2014).
▪ The EPDS is a 10-item, self-administered screen that can be scored
in approximately 5 minutes without specialized training.
▪ The EPDS specifically excludes questions about neurovegetative
symptoms (changes in sleep or appetite) that may be nonpathological in this population.
▪ Sensitivity: 0.67-1.0; specificity: 0.87 (using a cut-off of 13)
(USPSTF, 2016)
o Approve
o Reject
o Comments:
Appropriate screening intervals:
2. In the OB setting, PMAD screening will be performed at New OB, prenatal 2832-week, lactation problem, and 6-week postpartum visits.
o Rationale:
▪ “There is little evidence regarding the optimal timing for
screening” and a “pragmatic approach” should be used (Siu, 2016).
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▪
▪
▪

Women are significantly more likely to complete follow up mental
health evaluation if they had a positive depression screen prior to
delivery compared to after delivery (Venkatesh et al., 2016).
Depression during pregnancy is one of the strongest risk factors for
postpartum depression (Paschetta et al., 2014).
Postpartum depression tends to peak at 6 weeks, 2-3 months, and 6
months after delivery (Earls, 2010).

o Approve
o Reject
o Comments:
3. In the Emergency Department setting, women presenting to the ED with mental
health concerns will be asked “are you pregnant, or have you been pregnant
within the past year?” If the response if affirmative, case managers will
administer the EPDS.
o Rationale:
▪ There is currently no standardized method of identifying
pregnant/postpartum in the ED, nor is there a way of tracking ED
utilization for this population. Standardized screening and data
integration into the EHR (as a searchable value) will help identify
at-risk patients and help direct resource utilization.
o Approve
o Reject
o Comments:
Screening method and recording results in the medical record:
4. In the OB office or the ED, the nurse/case manager will give the patient a
clipboard with a paper copy of the EPDS and allow them to complete it privately.
The nurse/case manager will review the score, enter the responses into the EHR,
and communicate the results to the provider (in the ED this includes the ED
provider and the on-call psychiatrist).
o Rationale:
▪ The EPDS is designed to be self-administered. Values can be
quickly recorded in an EPIC EPDS flow-sheet allowing quick,
easy access by clinicians across the spectrum of care. (Until the
KH transition to EPIC, outpatient scores will be recorded in
NextGen and ED scores into Meditech.)
o Approve
o Reject
o Comments:
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Specific actions based on scores (questions 5-9 refer primarily to the outpatient
setting; in the ED clinician judgment should be used to determine whether the
patient meets criteria for admission and if admission is the most appropriate
intervention):
5. The provider will review the EPDS results and follow up directly with the patient
on any positive responses.
o Approve
o Reject
o Comments:
6. Special attention should be given to any positive responses to #10 (“Are your
worries or mood changing the way you do things? Are you having any scary
thoughts?”) Sound clinical judgment should be used in interpreting
responses/assessing risk.
o Approve
o Reject
o Comments:
7. For scores <10: (minimal symptoms)
o Scores <6: Provide encouragement, supportive counseling, education, and
encourage the patient to reach out if symptoms change (increase).
o Scores of 6=9: as above; follow up at future visits and consider repeat
screens
o Approve
o Reject
o Comments:
8. For scores 10-12: (mild to moderate symptoms)
o Discuss self-care, sleep hygiene, coping strategies. Offer referral to
counseling.
o Approve
o Reject
o Comments:
9. For scores of >12 (suggestive of major depression) OR positive response to
Question #10:
o Assess for safety: is there acute concern for psychiatric illness? (potential
for harm to self/others; inability to care for self/baby?)
▪ No: Refer to counseling; consider use of antidepressant
medication, consider consultation with/referral to psychiatric
provider.
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▪

Yes: If immediate concern for harm to self or others, arrange for
patient to go directly to the ED.

o Approve
o Reject
o Comments:
Method for transferring care: (these are dependent upon the proposed model
described below)
10. In the OB clinic, the clinician will ask the patient if she is currently established
with a mental health provider (prescriber, and/or therapist).
o Approve
o Reject
o Comments:
11. If yes, she will be referred back to that provider for follow up. A designee in the
OB office will contact the mental health clinician’s office with the results of the
EPDS and to coordinate care.
o Approve
o Reject
o Comments:
12. If no, she will be referred to the OB social worker, ideally with a warm hand-off.
o Approve
o Reject
o Comments:
13. For any OB office patient with an EPDS score => 12, the OB social worker will
attempt to contact the patient by phone for follow up within 72 hours.
o Approve
o Reject
o Comments:
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Ideal integrated behavioral health model:
14. In this proposed model, mental health services would be co-located in the
outpatient OB office.
o Rationale:
▪ Co-location improves treatment adherence because it normalizes
treatment and reduces stigma (Gjerdingen, Katon & Rich, 2008).
o Approve
o Reject
o Comments:
15. A full-time clinician (ideally a social worker) would work in the OB office
providing crisis intervention, case management, and psychotherapy.
o Rationale:
▪ A social worker (LCSW, LMSW) is ideally suited to match the
varying needs of this population. They can help the patient
navigate the healthcare system and can provide direct clinical care.
▪ Follow through rates improve when social workers are embedded
in the OB clinic (Venkatesh et al., 2016)
o Approve
o Reject
o Comments:
16. A part-time psychiatric nurse practitioner would work in the OB office providing
diagnostic assessment, consultations, and medication management. These
services would be available to patients from across the community, not restricted
to Kootenai Health clients. Phone consultation could be available outside office
hours.
o Rationale:
▪ The NP would have the flexibility to assume full care of some
patient’s mental health needs, especially in complicated cases that
OB providers are not comfortable handling, or to provide clinical
consultation to the KH and community providers to optimize
resource utilization (Gjerdingen, Katon & Rich, 2008).
o Approve
o Reject
o Comments:
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